<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Bogers, A.J.J.C.</title>
    <link>http://repub.eur.nl/res/aut/2546/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Surgical outcome of discrete subaortic stenosis in adults a multicenter study (Article)</title>
      <link>http://repub.eur.nl/res/pub/39706/</link>
      <pubDate>2013-03-19T00:00:00Z</pubDate>
      <description>Background: Discrete subaortic stenosis is notable for its unpredictable hemodynamic progression in childhood and high reoperation rate; however, data about adulthood are scarce. Methods and Results: Adult patients who previously underwent surgery for discrete subaortic stenosis were included in this retrospective multicenter cohort study. Mixed-effects and joint models were used to assess the postoperative progression of discrete subaortic stenosis and aortic regurgitation, as well as reoperation. A total of 313 patients at 4 centers were included (age at baseline, 20.2 years [25th-75th percentile, 18.4-31.0 years]; 52% male). Median follow-up duration was 12.9 years (25th-75th percentile, 6.2-20.1 years), yielding 5617 patient-years. The peak instantaneous left ventricular outflow tract gradient decreased from 75.7±28.0 mm Hg preoperatively to 15.1±14.1 mm Hg postoperatively (P&lt;0.001) and thereafter increased over time at a rate of 1.31±0.16 mm Hg/y (P=0.001). Mild aortic regurgitation was present in 68% but generally did not progress over time (P=0.76). A preoperative left ventricular outflow tract gradient ≥80 mm Hg was a predictor for progression to moderate aortic regurgitation postoperatively. Eighty patients required at least 1 reoperation (1.8% per patient-year). Predictors for reoperation included female sex (hazard ratio, 1.53; 95% confidence interval, 1.02-2.30) and left ventricular outflow tract gradient progression (hazard ratio, 1.45; 95% confidence interval, 1.31-1.62). Additional myectomy did not reduce the risk for reoperation (P=0.92) but significantly increased the risk of a complete heart block requiring pacemaker implantation (8.1% versus 1.7%; P=0.005). Conclusions: Survival is excellent after surgery for discrete subaortic stenosis; however, reoperation for recurrent discrete subaortic stenosis is not uncommon. Over time, the left ventricular outflow tract gradient slowly increases and mild aortic regurgitation is common, although generally nonprogressive over time. Myectomy does not show additional advantages, and because it is associated with an increased risk of complete heart block, it should not be performed routinely. </description>
    </item> <item>
      <title>Combined TCRG and TCRA TREC analysis reveals increased peripheral T-lymphocyte but constant intra-thymic proliferative history upon ageing (Article)</title>
      <link>http://repub.eur.nl/res/pub/37317/</link>
      <pubDate>2013-03-01T00:00:00Z</pubDate>
      <description>T-cell receptor (TCR) repertoire diversity, thymic output, clonal size and peripheral T-lymphocyte numbers largely depend on intra-thymic and post-thymic T-lymphocyte proliferation. However, quantitative insight into thymocyte and T-lymphocyte proliferation is still lacking. We developed a new TCRG-based TCR excision circle (TREC) assay, the Vγ-Jγ TREC assay, which we used together with an adjusted δREC-ψJα TREC assay to quantify the proliferative history of human thymocyte and T-lymphocyte subpopulations from children and adults. This revealed that thymocytes undergo ∼6-8 intra-thymic cell divisions from the double negative (DN) 3 developmental stage onwards, which appeared independent of age. Thus thymocyte proliferation after the DN3 developmental stages is stable and therefore not contributing to the reduced thymic output upon ageing. Cord blood naive T lymphocytes had already undergone ∼2-3 post-thymic cell divisions, which increased to ∼6-7 cell divisions in naive T lymphocytes of middle-aged adults, indicating the importance of homeostatic naive T-lymphocyte proliferation from a young age onwards in the maintenance of peripheral T-lymphocyte numbers. In conclusion, our data provide quantitative insight into the proliferative history of thymocyte and T-lymphocyte subpopulations and alterations herein upon ageing. This novel TREC assay approach could prove valuable in immune status monitoring in a variety of conditions. </description>
    </item> <item>
      <title>Appropriate Coronary Artery Bypass Grafting Use in the Percutaneous Coronary Intervention Era: Are We Finally Making Progress? (Article)</title>
      <link>http://repub.eur.nl/res/pub/39742/</link>
      <pubDate>2012-12-01T00:00:00Z</pubDate>
      <description>Appropriate use criteria integrate guidelines, clinical trial evidence, and expert opinion in order to determine the most appropriate care for a range of distinct clinical scenarios. Inappropriate use estimates cannot be neglected. Approximately 12%-14% of all percutaneous coronary interventions and 1%-2% of all coronary artery bypass grafting procedures in patients with stable angina are deemed inappropriate. Several reasons for this difference are identified. Continuous improvement of the criteria, multidisciplinary discussions, and the correct financial incentives will be essential in reducing the number of inappropriate procedures, improve patient outcomes, and contain costs. </description>
    </item> <item>
      <title>Reoperations on the pulmonary autograft and pulmonary homograft after the Ross procedure: An update on the German Dutch Ross Registry (Article)</title>
      <link>http://repub.eur.nl/res/pub/37353/</link>
      <pubDate>2012-10-01T00:00:00Z</pubDate>
      <description>Objectives: Reinterventions after the Ross procedure are a concern for patients and treating physicians. The scope of the present report was to provide an update on the reinterventions observed in the large patient population of the German-Dutch Ross Registry. Patients and Methods: From 1988 to 2011, 2023 patients (age, 39.05 ± 16.5 years; male patients, 1502; adults, 1642) underwent a Ross procedure in 13 centers. The mean follow-up was 7.1 ± 4.6 years (range, 0-22 years; 13,168 patient-years). Results: In the adult population, 120 autograft reinterventions in 113 patients (1.03%/patient-year) and 76 homograft reinterventions in 67 patients (0.65%/patient-year) and, in the pediatric population, 14 autograft reinterventions in 13 patients (0.91%/patient-year) and 42 homograft reinterventions in 31 patients (2.72%/patient-year) were observed. Of the autograft and homograft reinterventions, 17.9% and 21.2% were performed because of endocarditis, respectively. The subcoronary technique in the adult population resulted in significantly superior autograft durability (freedom from autograft reintervention: 97% at 10 years and 91% at 12 years; P &lt; .001). The root replacement technique without root reinforcement (hazard ratio, 2.4; 95% confidence interval, 1.4-4.1) and the presence of pure aortic insufficiency preoperatively (hazard ratio, 2.3; 95% confidence interval, 1.5-3.5) were statistically significant predictors for a shorter time to reoperation. The center volume had a significant influence on the long-term results. The freedom from homograft reoperation for the adults and pediatric population was 97% and 87% at 5 years and 93% and 79% at 12 years, respectively (P &lt; .001), with younger recipient and donor age being significant predictors of a shorter time to homograft reoperation. Conclusions: The autograft principle remains a valid option for young patients requiring aortic valve replacement. The risk of reoperation depends largely on the surgical technique used and the preoperative hemodynamics. Center experience and expertise also influence the long-term results. Adequate endocarditis prophylaxis might further reduce the need for reoperation.</description>
    </item> <item>
      <title>Results of balloon dilatation of stenotic homografts in pulmonary position in children and young adults (Article)</title>
      <link>http://repub.eur.nl/res/pub/37380/</link>
      <pubDate>2012-10-01T00:00:00Z</pubDate>
      <description>Objectives To evaluate the results of balloon dilatation of stenotic homografts in children, adolescents, and young adults and to identify factors that might influence or predict the effect of the dilatation. Background Homografts are widely used in congenital cardiac surgery; however, the longevity remains a problem mostly because of stenosis in the homograft. The effect of treatment by balloon dilatation is unclear. Methods In a retrospective study, the effect of balloon dilatation was determined by the percentage of reduction of the peak systolic pressure gradient over the homograft during catheterisation and the postponement of re-intervention or replacement of the homograft in months. Successful dilatations - defined in this study as a reduction of more than 33% and postponement of more than 18 months - were compared with unsuccessful dilatations in search of factors influencing or predicting the results. Results The mean reduction of the peak systolic pressure gradient was 30% in 40 procedures. Re-intervention or replacement of the homograft was postponed by a mean of 19 months. In all, 14 balloon dilatations (35%) were successful; the mean reduction was 49% and the mean postponement was 34 months. The time since homograft implantation, the presence of calcification, the homograft/balloon ratio, and the pressure applied during dilatation all tended to correlate with outcome, but were not statistically significant. Conclusions Balloon dilatation is able to reduce the peak systolic pressure gradient over homografts in a subgroup of patients and can be of clinical significance to postpone re-intervention or pulmonary valve replacement. </description>
    </item> <item>
      <title>Autograft and pulmonary allograft performance in the second post-operative decade after the Ross procedure: insights from the Rotterdam Prospective Cohort Study (Article)</title>
      <link>http://repub.eur.nl/res/pub/37728/</link>
      <pubDate>2012-09-01T00:00:00Z</pubDate>
      <description>The objective of the present study was to report our ongoing prospective cohort of autograft recipients with up to 21 years of follow-up. All consecutive patients (n = 161), operated between 1988 and 2010, were analysed. Mixed-effects models were used to assess changes in echocardiographic measurements (n = 1023) over time in both the autograft and the pulmonary allograft. The mean patient age was 20.9 years (range 0.05-52.7)-66.5% were male. Early mortality was 2.5% (n = 4), and eight additional patients died during a mean follow-up of 11.6 ± 5.7 years (range 0-21.5). Patient survival was 90% [95% confidence interval (CI), 78-95] up to 18 years. During the follow-up, 57 patients required a re-intervention related to the Ross operation. Freedom from autograft reoperation and allograft re-intervention was 51% (95% CI 38-63) and 82% (95% CI 71-89) after 18 years, respectively. No major changes were observed over time in autograft gradient, and allograft gradient and regurgitation. An initial increase of sinotubular junction and aortic anulus diameter was observed in the first 5 years after surgery. The only factor associated with an increased autograft reoperation rate was pre-operative pure aortic regurgitation (AR) (hazard ratio 1.88; 95% CI 1.04-3.39; P= 0.037). We observed good late survival in patients undergoing autograft procedure without reinforcement techniques. However, over half of the autografts failed prior to the end of the second decade. The reoperation rate and the results of echocardiographic measurements over time underline the importance of careful monitoring especially in the second decade after the initial autograft operation and in particular in patients with pre-operative AR.</description>
    </item> <item>
      <title>Reply to Liu et al. (Article)</title>
      <link>http://repub.eur.nl/res/pub/31118/</link>
      <pubDate>2011-09-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>No ross operation for patients with aortic regurgitation? (Article)</title>
      <link>http://repub.eur.nl/res/pub/33298/</link>
      <pubDate>2011-09-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Washing of irradiated red blood cells in paediatric cardiopulmonary bypass: is it clinically useful? A retrospective audit (Article)</title>
      <link>http://repub.eur.nl/res/pub/31184/</link>
      <pubDate>2011-08-02T00:00:00Z</pubDate>
      <description>Objective: Despite the introduction of smaller cardiopulmonary bypass (CPB) circuits for paediatrics, it is frequently necessary to add irradiated red blood cell concentrate (IRBC) to maintain adequate haemoglobin levels and the oxygen carrying capacity. Irradiation of blood weakens the cell membranes and results in an increase of lactate and potassium concentration. In addition, prolonged shelf time of IRBC may enhance its lactate level. To avoid the adverse effects of increased lactate and potassium concentration during paediatric bypass, prewashing of homologous blood in a cell-saving device was implemented at our institution. A retrospective audit of clinical data was performed to assess the relevance of this method. Methods: Preceding the introduction of the blood pre-washing, we investigated 14 units of IRBC for lactate, potassium levels and shelf time. Afterwards, we evaluated the CPB and laboratory data from 69 patients with body weight &lt;10 kg and the lactate levels in the priming of the bypass circuit. Results: The shelf time of blood units was 7.6 ± 2.7 days (minimum 5, maximum 14 days) with lactate concentration of 12.6 ± 2 mmol/l and potassium concentration of 16.2 ± 4.7 mmol/l. In the priming after pre-washing, the lactate concentration was significantly lower than the standard priming (2.5 ± 0.9 vs 4.5 ± 20 mmol/l, p = 0.002). At the start of bypass, the lactate concentration after pre-washing was still lower (1.5 ± 0.4 vs 1.9 ± 0.9 mmol/l; p = 0.04), but at the end of bypass we detected a significant increase of lactate in the pre-washed group (1.5 ± 0.4 vs 2.2 ± 1.1 mmol/l, p = 0.01). There was no significant difference between the groups at the end of bypass (1.8 ± 0.9 vs 2.2. ± 1.1 mmol/l, p = 0.17). Other clinical and patient data were not significantly different. Conclusions: Our retrospective audit shows that pre-washing of IRBCs is not associated with decreased lactate levels at the end of CPB compared with standard use of IRBCs, suggesting that the added value of pre-washing of IRBCs on minimisation of lactate levels during CPB remains doubtful. </description>
    </item> <item>
      <title>Intraoperative glycemic control without insulin infusion during pediatric cardiac surgery for congenital heart disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/26631/</link>
      <pubDate>2011-08-01T00:00:00Z</pubDate>
      <description>Summary Background: Many studies are reporting that the occurrence of hyperglycemia in the postoperative period is associated with increased morbidity and mortality rates in children after cardiac surgery for congenital heart disease. This study sought to determine blood glucose levels in standard pediatric cardiac anesthesiological management without insulin infusions. Methods: The study population consisted of 204 consecutive pediatric patients aged from 3 days to 15.4 years undergoing open cardiac surgery for congenital heart disease between June 2007 and January 2009. Glucose-containing fluids were not administrated intraoperatively, and all patients received high dose of opioids (sufentanil 10 mcg·kg-1) and steroids (30 mg·kg-1methylprednisolone) iv. Glucose levels were measured before CPB, 10 min after initiation of CPB, every hour on CPB, post-CPB, and on arrival at intensive care unit (ICU). Results: Intraoperatively, only one patient had a glucose level &lt;50 mg·dl-1(=34.2 mg·dl-1), 57/204 patients (27.9%) had at least one intraoperative glucose &gt;180 mg·dl-1, but only 12 patients (5.8%) had a glucose level &gt;180 mg·dl-1at ICU arrival. Thirty-day mortality was 1.5% (3/204). Younger age, lower body weight, and lower CPB temperature were associated with hyperglycemia at ICU arrival, as were higher RACHS and Aristotle severity scores. Conclusion: A conventional (no insulin, no glucose) anesthetic management seems sufficient in the vast majority of patients (96.5%). Special attention should be paid to small neonates with complex congenital heart surgery, in whom insulin treatment may be contemplated. </description>
    </item> <item>
      <title>Quality improvement, different roads to Rome (Article)</title>
      <link>http://repub.eur.nl/res/pub/24040/</link>
      <pubDate>2011-07-20T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Re-operations for aortic allograft root failure: Experience from a 21-year single-center prospective follow-up study (Article)</title>
      <link>http://repub.eur.nl/res/pub/26058/</link>
      <pubDate>2011-07-01T00:00:00Z</pubDate>
      <description>Objective: The study aims to report results of re-operations after aortic allograft root implantation. Methods: All consecutive patients in our prospective allograft database, who underwent aortic allograft root implantation, were selected for analysis, and additional information for patients who subsequently underwent re-operation was obtained from hospital records. Results: From 1989 to 2009, 262 aortic allograft root implantations were performed. Thirty-day mortality was 5.7%. During follow-up, 69 patients died. The actuarial survival was 77.0% (95% confidence interval (CI) 71-83%) after 10 years, and 65.1% (95% CI 57-74%) after 14 years. A total of 52 patients required re-operation. The actuarial freedom from allograft re-operation was 82.9% (Standard Error (SE) 2.9%) after 10 years and 55.7% (SE 5.7%) after 14 years. The actuarial median time to re-operation was 14.8 years. The indications for re-operation were structural valve dysfunction in 46 patients, endocarditis in two patients and non-structural valve dysfunction in four patients. The re-operations included 23 aortic valve replacements (mechanical prostheses 20 and bioprostheses 3), 27 aortic root replacements (mechanical conduits 21, aortic allografts five, and biological conduit one), one trans-apical valve implantation and one primary closure of a false aneurysm. The additional procedures were mitral valve repair (N=5), mitral valve replacement (N=1), ascending aortic replacement (N=5), and coronary artery bypass grafting (CABG) (N=4; in two patients unforeseen). Thirty-day mortality after re-operation occurred in two patients (3.9%). Five patients died during follow-up. The survival after re-operation was 87.1% (SE 5.5%) after 1 year and 79.3% (SE 7.4%) after 9 years. Conclusions: Re-operations after aortic allograft root implantation will be required in a substantial and growing number of patients. These re-operations, although technically demanding, can be performed with satisfying results. </description>
    </item> <item>
      <title>Right ventricular outflow tract reconstruction with an allograft conduit in patients after tetralogy of fallot correction: Long-term follow-up (Article)</title>
      <link>http://repub.eur.nl/res/pub/26558/</link>
      <pubDate>2011-07-01T00:00:00Z</pubDate>
      <description>Background: In tetralogy of Fallot (TOF) pulmonary regurgitation is a frequent complication after initial repair. The objective of the present study was to describe the long-term experience with the use of allograft conduits for right ventricular outflow tract (RVOT) reconstruction after correction of TOF in our institution. Methods: Between 1987 and 2009, 133 allografts were implanted in 126 patients (mean age, 27.8 years). The mean time from initial TOF repair to allograft implantation was 20.8 ± 8.8 years. Kaplan-Meier analyses were done for patient survival, freedom from allograft replacement and freedom from any cardiovascular event. Results: Hospital mortality was 1.5% (2 patients). Mean follow-up was 8.1 years. Ten other patients died during late follow-up, in 8 patients the cause was heart failure. Patient survival was 95% at 5 years, 91% at 10 years, and 80% at 15 years. Male sex, older patient age at the time of operation, and the use of preoperative diuretics were associated with increased risk of mortality during follow-up. Freedom from allograft replacement was 83% at 10 years and 70% at 15 years. Freedom from any valve-related event was 80% at 10 years and 67% at 15 years. Conclusions: Right ventricular outflow tract reconstruction after previous TOF repair can be performed with low risk and a low reintervention rate. Allograft conduits function satisfactorily in the pulmonary position at longer-term follow-up. Functional status after allograft implantation in patients with a previous correction of TOF remains good. There is concern about the long-term survival and the occurrence of heart failure. </description>
    </item> <item>
      <title>Nonrandomized data on drug-eluting stents compared with coronary bypass surgery: Caution with interpretation (Article)</title>
      <link>http://repub.eur.nl/res/pub/33915/</link>
      <pubDate>2011-06-14T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Details in a meta-analysis comparing mitral valve repair to replacement for ischemic regurgitation (Article)</title>
      <link>http://repub.eur.nl/res/pub/26218/</link>
      <pubDate>2011-06-02T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Right ventricular outflow tract reconstruction: The impact of allograft characteristics (Article)</title>
      <link>http://repub.eur.nl/res/pub/26245/</link>
      <pubDate>2011-06-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>A crucial factor in shared decision making: The team approach (Article)</title>
      <link>http://repub.eur.nl/res/pub/26179/</link>
      <pubDate>2011-05-28T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Survival of surgically treated infective endocarditis: A comparison with the general dutch population (Article)</title>
      <link>http://repub.eur.nl/res/pub/33464/</link>
      <pubDate>2011-05-01T00:00:00Z</pubDate>
      <description>Background: Infective endocarditis (IE) remains associated with high in-hospital and long-term mortality. The outcome of patients with IE who are operated on has never been put into perspective by comparing it to the age-matched and gender-matched general population. The aim of the present study was to evaluate the long-term mortality of patients with IE who undergo operation in relation to the age-matched and gender-matched general population. Methods: A retrospective observational cohort study of 138 patients with IE who underwent consecutive operations (19982007) was conducted. Cumulative survival was analyzed using the Kaplan-Meier method. Comparison of patient survival with the general population was done using the Dutch population life table. The standardized mortality ratio was used to assess the degree of late deaths. Results: The observed in-hospital mortality risk was 10.9%. The observed long-term survival was 85% (95% confidence interval, 78% to 90%), 74% (95% confidence interval, 65% to 79%), 71% (95% confidence interval, 62% to 78%) after 1, 5, and 10 years, respectively. Age-matched and gender-matched survival in the general population was 99%, 93%, and 80% after a follow-up period of 1, 5, and 10 years, respectively. The standardized mortality ratio was 0.99 (95% confidence interval, 0.67 to 1.31). Conclusions: Although mortality of IE patients who have undergone operation remains considerable during the immediate postoperative period, the mortality of hospital survivors is, with increasing follow-up time, comparable with the general population. </description>
    </item> <item>
      <title>Long-term outcome of right ventricular outflow tract reconstruction with bicuspidalized homografts (Article)</title>
      <link>http://repub.eur.nl/res/pub/26449/</link>
      <pubDate>2011-04-21T00:00:00Z</pubDate>
      <description>Objective: Given the shortage of small-sized cryopreserved homografts for right ventricle (RV) to pulmonary artery (PA) reconstructions, more readily available larger-sized homografts can be used after size reduction by bicuspidalization. The aim of our study was to determine and compare function over time of standard and bicuspidalized homografts in infants younger than 12 months, including patients with a Ross or extended Ross procedure. Methods: All consecutives infants under the age of 1 year, who underwent a surgical procedure in which a homograft was placed in the RV-PA position between January 1994 and April 2009, were included. Prospectively collected data from serial, standardized echocardiography from all patients were extracted from the database, and hospital records were retrospectively reviewed. Results: A total of 40 infants had a valved homograft conduit placed in the RV-PA position. In 20 of those patients, a bicuspidalized homograft was used. Twelve patients underwent a Ross procedure, of whom seven had an additional Konno-type aortic annulus enlargement. Median follow-up was 146 months (interquartile range (IQR), 117-170; total patient years: 178) in the group with standard use of the homograft and 95 months (IQR, 11-104; total patient years: 78) in the group with bicuspidalized conduits. Freedom from re-intervention (re-operation or percutaneous) was not different in the standard and bicuspidalized groups for all and Ross or Konno-Ross procedures (Tarone-Ware, p = 0.65 and p = 0.47, respectively). Consecutive echocardiographic maximum velocities in the right ventricular outflow tract were similar in the standard and bicuspidalized groups. Conclusion: When proper sized cryopreserved homografts for placement in the RV-PA position in Ross, Konno-Ross, and other procedures in infants under the age of 1 year are not readily available, bicuspidalized homografts provide an acceptable alternative. </description>
    </item> <item>
      <title>Risk stratification for adult congenital heart surgery (Article)</title>
      <link>http://repub.eur.nl/res/pub/34226/</link>
      <pubDate>2011-04-01T00:00:00Z</pubDate>
      <description>Objective: At this moment, no risk stratification models are available for adult congenital cardiac surgery. This study aims to identify a suitable stratification tool for the adult congenital heart surgery population. Pediatric congenital cardiac surgery score models were therefore tested in an adult congenital population. In addition, an age component was added to these models and performance was compared with the original score systems. Methods: The Risk Adjustment in Congenital Heart Surgery (RACHS-1), Basic Aristotle Score, Society of Thoracic Surgeons (STS)-European Association for Cardiothoracic Surgery (EACTS) Score and Comprehensive Aristotle Score were calculated for all adult patients who underwent congenital cardiac surgery between January 1990 and January 2007 in a single center (N= 963). In addition, an age component was added to these models. Discrimination was then tested for all models with and without the age component. Results: Application of the original pediatric risk scores resulted in c-statistics for 30-day mortality of 0.60, 0.60, 0.60, and 0.66 respectively. Combining these models with the age component resulted in significantly higher c-statistics of 0.69, 0.70, 0.69, and 0.76 respectively. Age as a sole predictor already resulted in a c-statistic of 0.67. Comparable results were found for 1-year mortality. Conclusions: The discriminatory power of the pediatric risk scores was suboptimal, but increased when adding age as a score component. The best performance was achieved by the combination of age and the Comprehensive Aristotle Score, for both 30-day and 1-year mortality. </description>
    </item> <item>
      <title>Disturbance of glucose homeostasis after pediatric cardiac surgery (Article)</title>
      <link>http://repub.eur.nl/res/pub/33716/</link>
      <pubDate>2011-02-01T00:00:00Z</pubDate>
      <description>This study aimed to evaluate the time course of perioperative blood glucose levels of children undergoing cardiac surgery for congenital heart disease in relation to endogenous stress hormones, inflammatory mediators, and exogenous factors such as caloric intake and glucocorticoid use. The study prospectively included 49 children undergoing cardiac surgery. Blood glucose levels, hormonal alterations, and inflammatory responses were investigated before and at the end of surgery, then 12 and 24 h afterward. In general, blood glucose levels were highest at the end of surgery. Hyperglycemia, defined as a glucose level higher than 8.3 mmol/l (&gt;150 mg/dl) was present in 52% of the children at the end of surgery. Spontaneous normalization of blood glucose occurred in 94% of the children within 24 h. During surgery, glucocorticoids were administered to 65% of the children, and this was the main factor associated with hyperglycemia at the end of surgery (determined by univariate analysis of variance). Hyperglycemia disappeared spontaneously without insulin therapy after 12-24 h for the majority of the children. Postoperative morbidity was low in the study group, so the presumed positive effects of glucocorticoids seemed to outweigh the adverse effects of iatrogenic hyperglycemia. </description>
    </item> <item>
      <title>Survival comparison of the ross procedure and mechanical valve replacement with optimal self-management anticoagulation therapy: Propensity-matched cohort study (Article)</title>
      <link>http://repub.eur.nl/res/pub/23644/</link>
      <pubDate>2011-01-04T00:00:00Z</pubDate>
      <description>Background-: It is suggested that in young adults the Ross procedure results in better late patient survival compared with mechanical prosthesis implantation. We performed a propensity score-matched study that assessed late survival in young adult patients after a Ross procedure versus that after mechanical aortic valve replacement with optimal self-management anticoagulation therapy. Methods and results-: We selected 918 Ross patients and 406 mechanical valve patients 18 to 60 years of age without dissection, aneurysm, or mitral valve replacement who survived an elective procedure (1994 to 2008). With the use of propensity score matching, late survival was compared between the 2 groups. Two hundred fifty-three patients with a mechanical valve (mean follow-up, 6.3 years) could be propensity matched to a Ross patient (mean follow-up, 5.1 years). Mean age of the matched cohort was 47.3 years in the Ross procedure group and 48.0 years in the mechanical valve group (P≤0.17); the ratio of male to female patients was 3.2 in the Ross procedure group and 2.7 in the mechanical valve group (P≤0.46). Linearized all-cause mortality rate was 0.53% per patient-year in the Ross procedure group compared with 0.30% per patient-year in the mechanical valve group (matched hazard ratio, 1.86; 95% confidence interval, 0.58 to 5.91; P≤0.32). Late survival was comparable to that of the general German population. Conclusions-: In comparable patients, there is no late survival difference in the first postoperative decade between the Ross procedure and mechanical aortic valve implantation with optimal anticoagulation self-management. Survival in these selected young adult patients closely resembles that of the general population, possibly as a result of highly specialized anticoagulation self-management, better timing of surgery, and improved patient selection in recent years. Copyright © 2011 American Heart Association.</description>
    </item> <item>
      <title>Clinical outcome and health-related quality of life after right-ventricular-outflow-tract reconstruction with an allograft conduit (Article)</title>
      <link>http://repub.eur.nl/res/pub/28247/</link>
      <pubDate>2010-12-06T00:00:00Z</pubDate>
      <description>Objective: Allograft conduits are used for reconstruction of the right ventricular outflow tract in congenital heart malformations (biventricular repair) and autograft procedures. A retrospective evaluation of allograft reconstruction of the right-ventricular-outflow-tract reconstruction was conducted and a cross-sectional quality of life study was performed. Methods: Between August 1986 and March 2009, 509 allografts (435 pulmonary and 74 aortic) were implanted in 463 pediatric and adult patients (308 right-sided congenital heart malformations and 155 autograft procedures). Perioperative and follow-up data were collected and analyzed. Kaplan-Meier analyses were done for survival, valve-related re-operation, and valve-related events. Cox regression analysis was used for evaluation of potential risk factors. In addition, the Short Form-36 was presented to patients to assess the perceived quality of life. The results of the Short Form-36 were compared to age-adjusted Dutch population norms. Results: The mean age at allograft implantation was 19 years (1 week-66 years). Mean follow-up was 9 years (2 days-22 years). Forty-eight patients died during follow-up. Patient survival was 93% at 10 years and 88% at 15 years. A total of 63 re-operations were required for allograft dysfunction in 58 patients. Freedom from valve-related re-operation was 89% at 10 years and 81% at 15 years. Freedom from valve-related events was 86% at 10 years and 74% at 15 years. Younger patient age (p = 0.007) and the use of an aortic allograft (p &lt; 0.001) were identified as independent risk factors for allograft re-operation. Patients between 14 and 40 years scored significantly lower on 'physical functioning' and 'general health' subscales than the general Dutch population, but scored better on the subscales 'emotional role functioning' and 'bodily pain'. Except for the subscale 'general health', on which patients within our study population scored lower, patients between 41 and 60 years had comparable average scores as the general Dutch population. The older patient group (61 years or older) had a better average score on the subscale 'bodily pain' and similar scores on other subscales with respect to the general Dutch population. Conclusions: Right-ventricular-outflow-tract reconstruction with an allograft conduit can be performed with good patient survival, acceptable long-term allograft durability, and good perceived quality of life. </description>
    </item> <item>
      <title>Aortic root reoperations after pulmonary autograft implantation (Article)</title>
      <link>http://repub.eur.nl/res/pub/21751/</link>
      <pubDate>2010-12-01T00:00:00Z</pubDate>
      <description>Objective: To report the results of aortic root reoperations after pulmonary autograft implantation. Methods: All consecutive patients in our prospective Ross research database were selected for analysis, and additional information for patients requiring reoperation was obtained from the hospital records. Results: From 1988 to 2009, 155 pulmonary autograft operations were performed. During this period, 41 patients required reoperation for aortic root dilatation and/or autograft valve insufficiency, in 8 patients combined with pulmonary allograft dysfunction. The freedom from autograft reoperation rate was 86% (standard error, 3.3%) after 10 years and 52% (standard error, 6.6%) after 15 years. The median interval to reoperation was 15.3 years. During reoperation, 39 patients underwent aortic root replacement (mechanical conduit, 31; stentless root, 2; allograft, 3; and valve sparing, 3), and 2 patients underwent valve replacement. In 8 patients this was combined with pulmonary allograft replacement. The technical difficulties encountered included bleeding at the sternal re-entry in 5 patients. No 30-day mortality occurred. The postoperative complications included reexploration for persistent blood loss in 3 patients and cerebrovascular accident in 3 patients. Two patients died during the follow-up period. The survival rate after reoperation was 94% (standard error, 4.1%) at 5 years. Conclusions: An increasing number of patients requires reoperation after pulmonary autograft implantation. These reoperations can be done with very low mortality and morbidity and excellent follow-up results.</description>
    </item> <item>
      <title>The evolution of advanced techniques for the management of symptomatic aortic stenosis in the elderly population: Conventional surgical management vs transcatheter valve implantation (Article)</title>
      <link>http://repub.eur.nl/res/pub/31576/</link>
      <pubDate>2010-12-01T00:00:00Z</pubDate>
      <description>The shifting age demographic of the adult population has affected every area of contemporary medical and surgical practice. Many more people are living well, not just into their 70s but into their 80s and beyond. Their expectations of treatment for every illness have shifted markedly upwards at the same time. Despite the decline in cases of rheumatic fever in Westernised populations in recent times, the ageing population has led to no decline in the prevalence of valvular aortic stenosis. This is now realised to be an active pro-inflammatory disease, rather than a degenerative process. Thus the condition has remained in the mainstream and continues to be responsible for considerable morbidity, hospitalisation and mortality among the elderly and very elderly. Management has always been based on the triage of cases for direct intervention to the valve by surgery. Just as expectations have risen from patients, the techniques, application and monitoring of cardiac surgery have also made huge strides forward to meet this aspiration. More and more, surgeons are routinely asked to consider procedures in frailer, more elderly patients with more severe disease and co-morbidity. Managing the stenosis is rarely the only issue confronting the operating surgeon. Attempts to provide alternatives to open valve replacement surgery on cardiopulmonary bypass have now emerged. These are based around the transcutaneous placement of a valve prosthesis. While these technologies were initially highly selective in their application, they have now reached a stage to be compared with contemporary standards of cardiac surgical practice. In this debate we have invited two international experts from the fields of cardiac surgery (Professor Jahangiri) and interventional cardiology (Professor Kappetein and colleagues) to take deliberately opposing positions on the evolving management of valvular aortic stenosis in the very elderly. We have asked them to try to consider the strengths of each route. Both approaches provide options for patients who only a few years ago might have been regarded as essentially untreatable. </description>
    </item> <item>
      <title>Medical predictors for long-term behavioral and emotional outcomes in children and adolescents after invasive treatment of congenital heart disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/21422/</link>
      <pubDate>2010-11-01T00:00:00Z</pubDate>
      <description>Background: The aim of the study was to test the following: (1) the predictive value of medical variables for long-term parent-reported behavioral and emotional problems in children and adolescents who underwent invasive treatment of congenital heart disease in infancy and (2) the relationship between parental psychological distress and parental reports on problems in children. Methods: The Child Behavior Checklist was used to investigate to what extent behavioral and emotional problems in 7- to 17-year-old children with congenital heart disease can be predicted by the following: (1) medical history, (2) therapeutic intervention and direct postinterventional course, (3) long-term medical course, (4) present contact with physicians, and (5) present medical status. The General Health Questionnaire was used to assess parental distress (especially anxiety). Results: Higher Child Behavior Checklist total problems scores were predicted by cardiac medication before therapeutic intervention. Palliative intervention (Rashkind procedure) before therapeutic intervention was associated with more favorable scores on total problems and externalizing. Long-term maternal distress was significantly related to parent-reported problems in children. Conclusion: Long-term behavioral and emotional outcomes are only marginally predicted by medical variables. In counseling of children with congenital heart disease and their parents, attention should be paid to long-term maternal distress that has an influence on parent-reported problems in children.</description>
    </item> <item>
      <title>Recovery of long-axis left ventricular function after aortic valve replacement in patients with severe aortic stenosis (Article)</title>
      <link>http://repub.eur.nl/res/pub/28012/</link>
      <pubDate>2010-11-01T00:00:00Z</pubDate>
      <description>Background: Patients with aortic stenosis (AS) should undergo aortic valve replacement (AVR) before irreversible LV dysfunction has developed. Assessment of long-axis left ventricular (LV) function may assist in proper timing of AVR. Objectives: To assess serial changes in long-axis LV function before and after AVR in patients with severe AS and preserved LV ejection fraction. Methods: The study comprised 27 consecutive patients (mean age 64.9 ± 11.7 years, 15 males) with symptomatic severe AS, scheduled for AVR. Seventeen subjects without known cardiac disease, matched for age, gender, LV ejection fraction and cardiovascular risk factors, served as a control group. Long-axis LV function assessment was done with tissue Doppler imaging at 3 weeks, 6 months, and 12 months after AVR. Results: Mean aortic valve area in the AS group was 0.70 ± 0.24 cm2. Pre-AVR peak systolic mitral annular velocities were significantly lower compared to controls (6.7 ± 1.5 vs. 8.9 ± 2.0 cm/s, P &lt; 0.05). Post-AVR peak systolic mitral annular velocities improved to 9.1 ± 2.9 at 3 weeks, 8.6 ± 2.7 at 6 months, and 8.1 ± 1.7 cm/s at 12 months (P &lt; 0.05). Improvements were seen over the whole range of pre-AVR peak systolic mitral annular velocities. Patients with improved Sm after AVR (defined as ≥10% compared to baseline values) did not differ in baseline characteristics as compared to those who did not improve. Conclusions: In patients with severe AS and preserved LV ejection fraction, abnormal systolic mitral annular velocities improve after AVR, independent of the pre-AVR value. </description>
    </item> <item>
      <title>Validation of a prognostic model to predict survival after non-small-cell lung cancer surgery (Article)</title>
      <link>http://repub.eur.nl/res/pub/28289/</link>
      <pubDate>2010-11-01T00:00:00Z</pubDate>
      <description>Objective: Surgery is the first choice of treatment for localised non-small-cell lung cancer (NSCLC). When making decisions regarding resection, physicians must balance the potential long-term benefits of surgery with the risk of surgery-related death, particularly among elderly patients with multiple co-morbid conditions. In 2005, a predictive model with a preoperative and a postoperative mode to predict survival of an individual patient after NSCLC surgery was created. This model combines the patient-, tumour- and treatment characteristics and can be used to assist in clinical decision making. Till present, this model has not been validated. The purpose of this study was to validate this model in patients operated on for primary NSCLC. Methods: A total of 126 patients underwent surgery for primary NSCLC between January 2002 and December 2006. Required model variables were collected for all patients and inserted into the model. To evaluate the performance of the two models, we assessed these models in terms of both discrimination (resolution) and calibration (reliability). The discriminative ability was measured using the c-index and calibration was evaluated by the Hosmer-Lemeshow goodness-of-fit test. Results: The median follow-up time was 3.4 years. Hospital mortality was 2.4%. One-, 2- and 3-year survival was 86%, 75% and 72%, respectively. The discriminative ability of the preoperative mode showed a c-statistic for 1-year survival of 0.68, for 2-year of 0.68 and for 3-year of 0.66. The postoperative model showed a discriminative ability for 1-year survival of 0.72, for 2-year of 0.76 and for 3-year of 0.77. Calibration was adequate for the first 2 years. The preoperative mode showed a p-value of 0.62 for 1-year survival and 0.14 for 2-year survival. Calibration was poor for 3-year survival (p= 0.0027). For the postoperative mode, calibration was quite similar with p-values of 0.4 for 1-year survival, 0.14 for 2-year survival and 0.003 for 3-year survival. Conclusions: The model adequately estimates the 1- and 2-year survival. Discrimination was good for 3-year survival. Inclusion of more factors with additional prognostic value could potentially further improve the accuracy of the model. </description>
    </item> <item>
      <title>Long term follow up after surgery in congenitally corrected transposition of the great arteries with a right ventricle in the systemic circulation (Article)</title>
      <link>http://repub.eur.nl/res/pub/24016/</link>
      <pubDate>2010-09-28T00:00:00Z</pubDate>
      <description>Aim of the study: To investigate the long-term outcome of surgical treatment for congenitally corrected transposition of the great arteries (CCTGA), in patients with biventricular repair with the right ventricle as systemic ventricle.Methods: A total of 32 patients with CCTGA were operated between January 1972 and October 2008. These operations comprised 18 patients with a repair with a normal left ventricular outflow tract, 11 patients with a Rastelli repair of the left ventricle to the pulmonary artery and 3 patients with a cardiac transplantation.Results: Excluding the cardiac transplantation patients, mean age at operation was 16 years (sd 15 years, range 1 week - 49 years). Median follow-up was 12 years (sd 10 years, range 7 days - 32 years). Survival obtained from Kaplan-Meier analysis at 20 years after surgery was 63% (CI 53-73%). For the non-Rastelli group these data at 20 years were 62% (CI 48-76%) and for the Rastelli group 67% (CI 51-83%). Freedom of reoperation at 20 years was 32% (CI 19-45%) in the overall group. In the non-Rastelli group the data at 20 years were 47% (CI 11-83%) and for the Rastelli group 21% (CI 0-54%) after almost 19 years.Conclusions: Long term follow up confirms that surgery in CCTGA with the right ventricle as systemic ventricle has a suboptimal survival and limited freedom of reoperation. Death occurred mostly as a result of cardiac failure. </description>
    </item> <item>
      <title>Major adverse cardiac and cerebrovascular events after the ross procedure: A report from the german-dutch ross registry (Article)</title>
      <link>http://repub.eur.nl/res/pub/27366/</link>
      <pubDate>2010-09-14T00:00:00Z</pubDate>
      <description>Background-: The purpose of the study is to report major cardiac and cerebrovascular events after the Ross procedure in the large adult and pediatric population of the German-Dutch Ross registry. These data could provide an additional basis for discussions among physicians and a source of information for patients. Methods and results-: One thousand six hundred twenty patients (1420 adults; 1211 male; mean age, 39.2±16.2 years) underwent a Ross procedure between 1988 and 2008. Follow-up was performed on an annual basis (median, 6.2 years; 10 747 patient-years). Early and late mortality were 1.2% (n=19) and 3.6% (n=58; 0.54%/patient-year), respectively. Ninety-three patients underwent 99 reinterventions on the autograft (0.92%/patient-year); 78 reinterventions in 63 patients on the pulmonary conduit were performed (0.73%/patient-year). Freedom from autograft or pulmonary conduit reoperation was 98.2%, 95.1%, and 89% at 1, 5, and 10 years, respectively. Preoperative aortic regurgitation and the root replacement technique without surgical autograft reinforcement were associated with a greater hazard for autograft reoperation. Major internal or external bleeding occurred in 17 (0.15%/patient-year), and a total of 38 patients had composite end point of thrombosis, embolism, or bleeding (0.35%/patient-year). Late endocarditis with medical (n=16) or surgical treatment (n=29) was observed in 38 patients (0.38%/patient-year). Freedom from any valve-related event was 94.9% at 1 year, 90.7% at 5 years, and 82.5% at 10 years. Conclusions-: Although longer follow-up of patients who undergo Ross operation is needed, the present series confirms that the autograft procedure is a valid option to treat aortic valve disease in selected patients. The nonreinforced full root technique and preoperative aortic regurgitation are predictors for autograft failure and warrant further consideration. </description>
    </item> <item>
      <title>Feasibility of real-time three-dimensional transesophageal echocardiography in type a aortic dissection (Article)</title>
      <link>http://repub.eur.nl/res/pub/20237/</link>
      <pubDate>2010-07-01T00:00:00Z</pubDate>
      <description>Transesophageal echocardiography (TEE) is the fastest method for diagnosing aortic dissection type A and allows 3D TEE, even in hemodynamically instable patients. 3D TEE may provide additional information on aortic morphology, the involvement of coronary arteries by the dissection and aortic valve function. In this regard 2D and 3D TEE might become the diagnostic method of choice in hemodynamically instable patients.</description>
    </item> <item>
      <title>Specific requirements for bloodless cardiopulmonary bypass in neonates and infants; A review (Article)</title>
      <link>http://repub.eur.nl/res/pub/21124/</link>
      <pubDate>2010-07-01T00:00:00Z</pubDate>
      <description>A miniaturized cardiopulmonary bypass circuit enables the safe performance, in selected pediatric patients, of bloodless open heart surgery. As the latest survival rates in neonatal and infant cardiac surgery have become satisfactory, investigators have concentrated upon the improvement of existing procedures. Institutional guidelines and multidisciplinary efforts undertaken in the pre- and postoperative periods are of great importance, concerning bloodless CPB and should be seriously pursued by all involved caregivers. This review reflects upon the selective, most relevant requirements for success of asanguinous neonatal and infant CPB: acceptable level of hemodilution during the CPB, patient preoperative hematocrit value and volume of CPB circuit. We present an assessment of practical measures that were also adapted in our institution to achieve an asanguinous CPB for neonatal and infant patients.</description>
    </item> <item>
      <title>Pulmonary autograft valve explants show typical degeneration (Article)</title>
      <link>http://repub.eur.nl/res/pub/27621/</link>
      <pubDate>2010-06-01T00:00:00Z</pubDate>
      <description>Objectives: We sought to evaluate the microscopic characteristics of pulmonary autograft valve explants. Methods: Cell density and thickness of the autograft valve ventricularis were determined and compared with those of normal aortic and pulmonary valves (n = 11). Cellular phenotype and extracellular matrix involvement were assessed with immunohistochemistry. Collagen 3-dimensional architecture was studied by means of confocal microscopy. Results: The autograft valve exhibited characteristic thickening of the ventricularis compared with the normal aortic and pulmonary valves (137 vs 77 [P = .058] vs 37 μm [P = .002], respectively). Its cell number was increased compared with those of the normal aortic and pulmonary valves (396 vs 230 [P = .02] vs 303 [P = .083], respectively). Myofibroblasts and stressed endothelial cells, both of which were present in pulmonary autografts, were absent in control valves. The exclusive presence of matrix metalloproteinase 1 was an additional sign of extracellular matrix turnover. Apoptosis, elastinolysis, cell proliferation, and senescence were not expressed. Dense fibrosis of the autograft ventricularis with relatively well-aligned collagen fibers was observed with confocal microscopy. Conclusions: Fibrous hyperplasia of the ventricularis and cellular and extracellular matrix characteristics of active remodeling were a consistent finding in pulmonary autograft valve explants. The observations suggest a primary valve-related cause to be involved in pulmonary autograft valve failure. </description>
    </item> <item>
      <title>Re-interventions on the autograft and the homograft after the Ross operation in children (Article)</title>
      <link>http://repub.eur.nl/res/pub/28308/</link>
      <pubDate>2010-05-01T00:00:00Z</pubDate>
      <description>Background: For children who require aortic valve replacement, the pulmonary autograft may be the ideal substitute. However, re-operations for conduit exchange in the pulmonary position are inevitable. In addition, re-operations on the autograft may be necessary due to dilatation and neo-aortic insufficiency. We sought to assess predictors for re-intervention in an international Ross-operated paediatric population. Methods: Data of 152 children below 16 years of age at the time of the Ross operation were analysed using Cox proportional hazard modelling. Mean follow-up time was 6.1 ± 4.2 years. Results: The median age at the time of the Ross operation was 10.1 years (range 54 days to 15 years). Early mortality was 2.6%. Survival at 5 and 10 years was 93.9 ± 2.0% and 90.4 ± 3.1%, respectively. Seven patients required autograft re-intervention (explantation n = 6 and reconstruction n = 1). Freedom from autograft re-intervention at 5 and 10 years was 99.3 ± 0.7% and 95.5 ± 2.7%, respectively. Prior endocarditis (p = 0.061), prior aortic regurgitation (p = 0.061) and longer follow-up time (p = 0.036) emerged as risk factors for autograft re-intervention. Seventeen patients required 36 conduit re-interventions (replacement n = 16, percutaneous valvuloplasty n = 10). Freedom from conduit re-intervention at 5 and 10 years was 89.3 ± 2.9% and 79.6 ± 6.1%, respectively. Implantation of an aortic homograft (p = 0.013), and smaller conduit size (p = 0.074) emerged as risk factors for conduit re-intervention. Conclusions: There is a consistent need for conduit re-intervention following the Ross operation in children. Re-interventions on the autograft are rare within the first decade after surgery. However, the number of autograft re-interventions may increase after the first decade, since longer follow-up time is a risk factor for autograft failure. </description>
    </item> <item>
      <title>The Ross operation in children. Results from the European Ross Registry [Die Ross-Operation bei Kindern. Ergebnisse aus dem Europäischen Ross-Register] (Article)</title>
      <link>http://repub.eur.nl/res/pub/19780/</link>
      <pubDate>2010-04-01T00:00:00Z</pubDate>
      <description>Objectives: To determine the durability of autografts and homografts after Ross operations in children. Patients and methods: The data of 152 children &lt;16 years were analyzed using the Cox proportional hazards model and hierarchical multilevel modeling. Results: Autograft regurgitation increased with sinotubular junction diameter (p=0.028). The homograft gradient increased within the first 2 years (4.2 mmHg/year, p&lt;0.001). Freedom from autograft and homograft reintervention at 10 years was 95.5±2.7% and 79.6±6.1%, respectively. Longer follow-up time was a risk factor for autograft reintervention (p=0.036). Use of an aortic homograft was a risk factor for conduit reintervention (p=0.013). Conclusions: Reinterventions are necessary for autograft regurgitation and homograft stenosis. Increasing sinotubular junction diameters explain autograft regurgitation. Using pulmonary homografts delays the development of a homograft gradient.</description>
    </item> <item>
      <title>Results of staged total cavopulmonary connection for functionally univentricular hearts; comparison of intra-atrial lateral tunnel and extracardiac conduit (Article)</title>
      <link>http://repub.eur.nl/res/pub/28313/</link>
      <pubDate>2010-04-01T00:00:00Z</pubDate>
      <description>Objectives: This study aims to compare the outcome of the two co-existing modifications of staged total cavopulmonary connection (TCPC) - the intra-atrial lateral tunnel (ILT) and the extracardiac conduit (ECC). Methods: We included 209 patients after staged TCPC (102 ILT and 107 ECC), operated on between 1988 and 2008. Medical and surgical records were reviewed for (1) patient demographics and cardiac anatomy; (2) pre-Fontan procedures; (3) pre-Fontan haemodynamics and cardiac functional status; (4) operative details; (5) postoperative hospital course; (6) follow-up information on arrhythmias and thrombo-embolic events; (7) post-Fontan interventions; and (8) clinical status at last follow-up until June 2008. Results: Median follow-up duration was 4.3 years (interquartile range 1.5-7.4 years). At 6-year follow-up, freedom from Fontan failure (i.e., mortality or re-operations for Fontan failure) was 83% for the ILT and 79% for the ECC groups (p = 0.6); freedom from late re-operations (other than re-operations for Fontan failure) was 79% for the ILT and the ECC groups and freedom from arrhythmias was 83% for the ILT, and 92% for the ECC groups (p = 0.022). Multivariable Cox regression analysis identified intensive care unit stay and cardiopulmonary bypass time as risk factors for Fontan failure, but they were not strong predictors. Right ventricular morphology was identified as a risk factor for arrhythmias. The occurrence of thrombo-embolic events was low with no difference between the ILT and the ECC groups, and irrespective of the postoperative use of anticoagulant or anti-platelet aggregation therapy. At most recent follow-up, sinus rhythm was present in 70% of patients; in 23% of the patients, ventricular function was found to be moderately or severely impaired at echocardiography. Conclusions: Outcome after staged ILT- and ECC-type Fontan operations is good, with comparable freedom from late re-operations and freedom from Fontan failure at 6-year follow-up. The incidence of arrhythmias was significantly lower in the ECC group. Right ventricular morphology was identified as a risk factor for arrhythmias. </description>
    </item> <item>
      <title>Relevance of colloid oncotic pressure regulation during neonatal and infant cardiopulmonary bypass: a prospective randomized study (Article)</title>
      <link>http://repub.eur.nl/res/pub/21458/</link>
      <pubDate>2010-01-01T00:00:00Z</pubDate>
      <description>Objective: In neonatal and infant cardiac surgery with cardiopulmonary bypass (CPB), hemodilution with reduction of plasma albumin concentration and low colloid oncotic pressure (COP) are the main factors associated with tissue edema and postoperative weight gain. The aim of our study was to evaluate the influence of two different COP regulatory strategies on post-bypass body weight gain, fluid balance, and clinical outcomes. Methods: Seventy elective patients with body weight &lt; 10 kg underwent first-time cardiac surgery with CPB and were randomized into two groups. The standard COP group received 0.5 g kg-1  of human albumin in the priming and, during CPB, albumin was added to maintain the COP &gt; 15 mmHg. In the high COP group, albumin concentration in the priming was 5% and, during CPB, the COP was maintained above 18 mmHg. All patients were monitored before, during and until 24 h postoperatively. Data were collected on body weight gain, COP, albumin concentration, fluids transfusion, blood loss, urine production and laboratory results. Results: Patients' demographics and operative data were comparable. Although the high COP group had perioperatively significantly higher COP and albumin concentration than the standard COP group, no significant difference was found in the body weight gain. There were also no significant differences between the groups with respect to fluid balance, urine output and blood loss. However, the high COP group had significantly shorter postoperative duration of mechanical ventilation (10 h vs 14 h, p = 0.02) and lower plasma lactate concentration post operation (1.1 mmol l-1 vs 1.4 mmol l-1, p = 0.046). Conclusions: The COP regulatory strategy for neonatal and infant CPB, based upon the 5% concentration of albumin in the priming and a COP target of 18 mmHg during bypass, better preserves the plasma albumin concentration within the physiological range and stabilizes the colloid pressure than the standard strategy (0.5 g kg-1 albumin in the priming and bypass COP target at 15 mmHg). Nevertheless, only the lower postoperative plasma lactate concentration and the shorter duration of mechanical ventilation in the high COP group indicated the potential clinical benefit of this new strategy.</description>
    </item> <item>
      <title>Surgical Treatment of Active Native Aortic Valve Endocarditis With Allografts and Mechanical Prostheses (Article)</title>
      <link>http://repub.eur.nl/res/pub/24283/</link>
      <pubDate>2009-12-01T00:00:00Z</pubDate>
      <description>Background: Surgical intervention for persistent active native aortic valve endocarditis (NVE) remains challenging. We analyzed our combined experience with allografts and mechanical prostheses (MP) in NVE operations. Methods: Between 1980 and 2002, 138 patients (81% males) underwent aortic valve replacement for NVE in 2 centers (106 allografts; 32 MPs). Perioperative characteristics and early and late morbidity and mortality were analyzed. Results: Mean age was 47 years (range, 14 to 76 years), and 34% required emergency surgery. Abscess rate was 38% for allografts vs 18% for MPs. Concomitant mitral valve replacement was required in 38% MP patients and in 5% allograft patients. Hospital mortality was 8% (n = 11; p = 0.25): 10 allograft patients (9%) and 1 MP patient (3%). During a mean 8-year follow-up (range, 0 to 25 years) 33 patients died: 22 allograft (24%) and 11 MP patients (21%; p = 0.14). Survival at 15 years was 59% ± 6% for allograft patients and 66% ± 9% for MP patients (p = 0.68). Late recurrent endocarditis developed in 6 allograft patients and 1 MP patient (p = 0.29). Overall 15-year freedom from reoperation was 76% ± 9% for allografts and 93% ± 6% for MPs (p = 0.02). Conclusions: Mechanical prostheses have comparable rates of midterm survival and freedom from recurrent infection. However, this is in combination with extensive excision of destructive tissue in a specific patient subset. Allograft reoperation rates increase with time. The importance of the mechanical prosthesis in NVE might be established in the coming years. </description>
    </item> <item>
      <title>Rapid method for intraoperative assessment of aortic coarctation using three-dimensional echocardiography (Article)</title>
      <link>http://repub.eur.nl/res/pub/24642/</link>
      <pubDate>2009-12-01T00:00:00Z</pubDate>
      <description>Aims The availability of three-dimensional (3D) echography with its multiplanar review analysis software on board now allows detailed examination in assessing morphological details. We evaluated the feasibility of 3D echography in assessing intraoperative morphological details of aortic coarctation (CoA) and its repair.Methods and resultsNine consecutive children scheduled for surgery of CoA were intraoperatively evaluated. Intraoperative 3D data sets were taken and analysed online before resection of the coarctation, showing the cross-sectional area (CSA) of the proximal aorta, coarctation, and the distal descending aorta. After resection of the coarctation and extended end-to-end anastomosis, a 3D data set was recorded to analyse the CSA of the anastomosis. In nine out of nine consecutive procedures, intraoperative 3D echography permitted comprehensive viewing and measuring of CoA and its repair. In three out of nine surgical procedures, intraoperative 3D echography provided additional information to support surgical decision-making. ConclusionIntraoperative 3D echography is a feasible non-invasive imaging modality for intraoperative assessment of CoA and its repair, which provides useful additional information.</description>
    </item> <item>
      <title>Alveolar recruitment strategy and PEEP improve oxygenation, dynamic compliance of respiratory system and end-expiratory lung volume in pediatric patients undergoing cardiac surgery for congenital heart disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/24806/</link>
      <pubDate>2009-12-01T00:00:00Z</pubDate>
      <description>Objective: Optimizing alveolar recruitment by alveolar recruitment strategy (ARS) and maintaining lung volume with adequate positive end-expiratory pressure (PEEP) allow preventing ventilator-induced lung injury (VILI). Knowing that PEEP has its most beneficial effects when dynamic compliance of respiratory system (Crs) is maximized, we hypothesize that the use of 8 cm H2O PEEP with ARS results in an increase in Crs and end-expiratory lung volume (EELV) compared to 8 cm H2O PEEP without ARS and to zero PEEP in pediatric patients undergoing cardiac surgery for congenital heart disease. Methods: Twenty consecutive children were studied. Three different ventilation strategies were applied to each patient in the following order: 0 cm H2O PEEP, 8 cm H2O PEEP without an ARS, and 8 cm H2O PEEP with a standardized ARS. At the end of each ventilation strategy, Crs, EELV, and arterial blood gases were measured. Results: EELV, Crs, and PaO2/FiO2ratio changed significantly (P &lt; 0.001) with the application of 8 cm H2O + ARS. Mean PaCO2- PETCO2difference between 0 PEEP and 8 cm H2O PEEP + ARS was also significant (P &lt; 0.05). Conclusion: An alveolar recruitment strategy with relative high PEEP significantly improves Crs, oxygenation, PaCO2- PETCO2difference, and EELV in pediatric patients undergoing cardiac surgery for congenital heart disease. </description>
    </item> <item>
      <title>How to assess risks of valve surgery: Quality, implementation and future of risk models (Article)</title>
      <link>http://repub.eur.nl/res/pub/27211/</link>
      <pubDate>2009-12-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Measurement of end-expiratory lung volume in intubated children without interruption of mechanical ventilation (Article)</title>
      <link>http://repub.eur.nl/res/pub/24151/</link>
      <pubDate>2009-10-01T00:00:00Z</pubDate>
      <description>Purpose: Monitoring end-expiratory lung volume (EELV) is a valuable tool to optimize respiratory settings that could be of particular importance in mechanically ventilated pediatric patients. We evaluated the feasibility and precision of an intensive care unit (ICU) ventilator with an in-built nitrogen washout/washin technique in mechanically ventilated pediatric patients. Methods: Duplicate EELV measurements were performed in 30 patients between 5 kg and 43 kg after cardiac surgery (age, median + range: 26, 3-141 months). All measurements were taken during pressure-controlled ventilation at 0 cm H2O of positive end-expiratory pressure (PEEP). Results: Linear regression between duplicate measurements was excellent (R2= 0.99). Also, there was good agreement between duplicate measurements, bias ± SD: -0.3% (-1.5 mL) ± 5.9% (19.2 mL). Mean EELV ± SD was 19.6 ± 5.1 mL/kg at 0 cm H2O PEEP. EELV correlated with age (p &lt; 0.001, r = 0.92, R2= 0.78), body weight (p &lt; 0.001, r = 0.91, R2= 0.82) and height (p &lt; 0.001, r = 0.94, R2= 0.75). Conclusion: This ICU ventilator with an in-built nitrogen washout/washin EELV technique can measure EELV with precision, and can easily be used for mechanically ventilated pediatric patients.</description>
    </item> <item>
      <title>A New Transesophageal Probe for Newborns (Article)</title>
      <link>http://repub.eur.nl/res/pub/24516/</link>
      <pubDate>2009-10-01T00:00:00Z</pubDate>
      <description>Current transesophageal probes are designed for adults and are used both in the operating theatre for monitoring as well as in the outpatient clinic for patients with specific indications, like obesity, artificial valves, etc. For newborns (&lt;5 kg), transesophageal echocardiography (TEE) is not possible because the current probes are too big for introducing them into the esophagus. There is a clear need for a small probe in newborns that are scheduled for complicated cardiac surgery and catheterization. We present the design and realization of a small TEE phased array probe with a tube diameter of 5.2 mm and head size of only 8.2-7 mm. The number of elements is 48 and the center frequency of the probe is 7.5 MHz. A separate clinical evaluation study was carried out in 42 patients (Scohy et al. 2007). (E-mail: n.dejong@erasmusmc.nl). </description>
    </item> <item>
      <title>Autograft reinforcement to preserve autograft function after the ross procedure: a report from the german-dutch ross registry. (Article)</title>
      <link>http://repub.eur.nl/res/pub/25287/</link>
      <pubDate>2009-09-15T00:00:00Z</pubDate>
      <description>BACKGROUND: Autograft reinforcement interventions (R) during the Ross procedure are intended to preserve autograft function and improve durability. The aim of this study is to evaluate this hypothesis. METHODS AND RESULTS: 1335 adult patients (mean age:43.5+/-12.0 years) underwent a Ross procedure (subcoronary, SC, n=637; root replacement, Root, n=698). 592 patients received R of the annulus, sinotubular junction, or both. Regular clinical and echocardiographic follow-up was performed (mean:6.09+/-3.97, range:0.01 to 19.2 years). Longitudinal assessment of autograft function with time was performed using multilevel modeling techniques. The Root without R (Root-R) group was associated with a 6x increased reoperation rate compared to Root with R (Root+R), SC with R (SC+R), and without R (SC-R; 12.9% versus 2.3% versus 2.5%.versus 2.6%, respectively; P&lt;0.001). SC and Root groups had similar rate of aortic regurgitation (AR) development over time. Root+R patients had no progression of AR, whereas Root-R had 6 times higher AR development compared to Root+R. In SC, R had no remarkable effect on the annual AR progression. The SC technique was associated with lower rates of autograft dilatation at all levels of the aortic root compared to the Root techniques. R did not influence autograft dilatation rates in the Root group. CONCLUSIONS: For the time period of the study surgical autograft stabilization techniques preserve autograft function and result in significantly lower reoperation rates. The nonreinforced Root was associated with significant adverse outcome. Therefore, surgical stabilization of the autograft is advisable to preserve long-term autograft function, especially in the Root Ross procedure.</description>
    </item> <item>
      <title>Anatomical and functional assessment of single left internal mammary artery versus arterial T-grafts 12 years after surgery (Article)</title>
      <link>http://repub.eur.nl/res/pub/25394/</link>
      <pubDate>2009-09-01T00:00:00Z</pubDate>
      <description>We determined whether ultrasonographic left internal mammary artery (LIMA) findings correspond with 64 multislice computed tomography (MSCT) in patients 12 years after coronary artery bypass grafting. We included 34 patients (63.2±9.2 years), 16 with conventional single LIMA (group I) and 18 arterial T-grafts (group II), in a cross-sectional study. Patients underwent transthoracic proximal LIMA ultrasonography at rest and during the Azoulay maneuver, transthoracic echocardiography of the left ventricle and 64-MSCT, 11.5±1.4 years postoperatively. MSCT scans showed three string sign LIMA grafts (19%) in group I and three distal string sign LIMA grafts (17%) and 16 occluded T-graft anastomoses (22%) in group II. LIMA diameters and areas are significantly larger in group II in the origin, 3.5±0.7 vs. 2.5±0.5 mm, P=0.00007 and 0.09±0.04 vs. 0.05±0.02 cm2, P=0.00019 and in the third intercostal space, 3.4±0.7 vs. 2.5±0.5 mm, P=0.00009 and 0.09±0.03 vs. 0.05±0.02 cm2, P=0.000047. Most ultrasonographic LIMA findings do not differ between the groups. Thus, proximal LIMA diameters and areas are significantly larger in T-grafts and ultrasonographic variables equalize between the groups at rest and during the Azoulay maneuver 12 years after surgery.</description>
    </item> <item>
      <title>Improved aortic distensibility after aortic homograft root replacement at long-term follow-up (Article)</title>
      <link>http://repub.eur.nl/res/pub/24383/</link>
      <pubDate>2009-08-14T00:00:00Z</pubDate>
      <description>Background: The ideal substitute for a diseased aortic valve remains unclear. Usually, the aortic full root replacement (FRR) technique is used, in which the native aortic root is removed and entirely replaced with the homograft aortic root, the coronary arteries being reimplanted into the homograft. The aim of the present study was to examine alterations in aortic size and stiffness in patients after FRR. Methods and patients: The study comprised 13 patients (mean age 46 ± 15 years, 10 males) who underwent FRR because of acute aortic regurgitation due to endocarditis in 6 patients (46%) and aortic valve stenosis with or without regurgitation in 7 patients (54%). These patients underwent transthoracic two-dimensional echocardiography before FRR, before discharge (9 ± 8 days post-FRR), and 6 months and 24 months after FRR. Systolic and diastolic ascending aortic diameters were recorded in M-mode at the middle of the ascending aorta, 3 to 4 cm above the aortic valve from a parasternal long-axis view. An aortic stiffness index (β) was calculated. The results were compared to 13 age-, gender- and risk factor-matched controls. Results: The aortic stiffness index first non-significantly deteriorated from 12.7 ± 8.1 to 16.4 ± 9.1 immediately after FRR. Subsequently, an improvement to 14.2 ± 7.1 (after 6 months) and 7.1 ± 4.8 (after 24 months, P &lt; 0.05) was seen. Conclusions: FRR is associated with a transient immediate post-FRR deterioration followed by a progressive improvement in aortic distensibility. </description>
    </item> <item>
      <title>Neoaortic Root Diameters and Aortic Regurgitation in Children After the Ross Operation (Article)</title>
      <link>http://repub.eur.nl/res/pub/24280/</link>
      <pubDate>2009-08-01T00:00:00Z</pubDate>
      <description>Background: For children who require aortic valve replacement, the Ross operation provides a unique advantage of growth potential of the pulmonary autograft in the aortic position. This study assessed the progression of autograft root diameters and its effect on aortic regurgitation (AR). Methods: Neoaortic echo dimensions from 48 children (&lt;16 years) undergoing Ross operation who had follow-up echocardiograms before age 20 were analyzed (mean follow-up, 5.1 ± 3.3 years). Results: The mean age at the time of the Ross operation was 10.0 ± 4.3 years. Mean z values of the neoaortic annulus (1.5 ± 0.4), sinus (2.5 ± 0.4), and sinotubular junction (2.6 ± 0.9) when the autograft was implanted were significantly larger compared with normal values (p &lt; 0.001, all). The mean z values significantly increased with follow-up at the level of the sinus (0.5 ± 0.1/year, p &lt; 0.001) and the sinotubular junction (0.7 ± 0.2, p &lt; 0.001), but not at the level of the annulus (0.1 ± 0.1, p = 0.59). AR increased with follow-up time (0.07 ± 0.02 grade/year, p &lt; 0.001). AR increased with sinotubular junction diameter (p = 0.028), but there was not significant evidence of an association with annulus diameter (p = 0.25) or sinus diameter (p = 0.40). Conclusions: Children undergoing Ross operation have larger neoaortic root dimensions than healthy children. Growth of the annulus matches somatic growth. The diameters of the sinus and the sinotubular junction increase significantly relative to somatic growth. The latter may explain the development of AR. </description>
    </item> <item>
      <title>Homograft Performance in Children After the Ross Operation (Article)</title>
      <link>http://repub.eur.nl/res/pub/24281/</link>
      <pubDate>2009-08-01T00:00:00Z</pubDate>
      <description>Background: The Ross operation may be the ideal aortic valve replacement in pediatric patients. However, reoperations for replacement of the homograft in the pulmonary position are inevitable. This study determined influencing factors for the development of homograft stenosis and regurgitation in pediatric Ross patients. Methods: Follow-up echocardiograms of 116 children (86 boys) undergoing Ross operations at a mean age, 9.3 ± 4.9 years were analyzed using hierarchic multilevel modeling. Mean duration of the echocardiographic follow-up was 5.3 ± 4.2 years (609 patient-years, 398 examinations). Results: Median homograft diameter z value was 0.3 (range -2.2 to +7.3). Mean homograft pressure gradient at implantation was 5.0 mm Hg with a significant increase of 4.2 mm Hg/y (p &lt; 0.001) within the first 2 years and a steady state thereafter. Older donor age was significantly associated with lower mean pressure gradient at implantation (p = 0.037). Larger z value had no significant influence on the annual increase of pressure gradient (p = 0.87). Mean grade of regurgitation at implantation was 0.9, without significant annual increase (0.02 grade/y, (p = = 0.32). Older recipient (p = 0.005) and donor age (p &lt; 0.0001) were significantly associated with lower mean regurgitation at implantation. Larger z value was associated with a higher annual increase of regurgitation (p = 0.014). Conclusions: Relevant midterm homograft regurgitation is rare in children after the Ross operation. However, a significant annual increase occurs in the pressure gradient that cannot be influenced by larger graft size. Homograft oversizing may lead to a higher annual increase of regurgitation. </description>
    </item> <item>
      <title>Prognosis of patients undergoing cardiac surgery and treated with intra-aortic balloon pump counterpulsation prior to surgery: A long-term follow-up study (Article)</title>
      <link>http://repub.eur.nl/res/pub/25395/</link>
      <pubDate>2009-08-01T00:00:00Z</pubDate>
      <description>The aim of this study was to evaluate short- and long-term outcome in patients undergoing coronary artery bypass grafting (CABG), who received an intra-aortic balloon pump (IABP) prior to surgery. Between January 1990 and June 2004, all patients (n=154) who received an IABP prior to on-pump CABG in our center were included. Patients received the IABP for vital indications (i.e. either unstable angina refractory to medical therapy or cardiogenic shock; group 1: n=99) or for prophylactic reasons (group 2: n=55). A Cox proportional hazards model was used to identify predictors of long-term all-cause mortality. Compared with the EuroSCORE predictive model, observed 30-day mortality in group 1 (15.2%) was slightly higher than predicted (10.3%). A decrease in 30-day mortality occurred in group 2 (median predicted mortality was 7.2% and observed was 0%). Cumulative 1-, 5-, and 6-year survival was 82.8±3.8%, 70.1±4.9%, and 67.3±5.1% for group 1 vs. 98.2±1.8%, 84.0±5.6% and 84.0±5.6% for group 2 (Log-rank: P=0.02). Logistic EuroSCORE (HR 1.03 w1.01-1.05x, Ps0.007) was an independent predictor of long-term all-cause mortality.</description>
    </item> <item>
      <title>Seventeen years of adult congenital heart surgery: a single centre experience (Article)</title>
      <link>http://repub.eur.nl/res/pub/24345/</link>
      <pubDate>2009-07-01T00:00:00Z</pubDate>
      <description>Objective: With a growing number of children with congenital heart disease (CHD) reaching adulthood, an extensive experience with cardiac surgery in adults with CHD is accumulating. To increase insight in this patient category we report our 17-year single centre experience including predictors for adverse outcome and EuroSCORE performance. Methods: Patients and operative characteristics of all consecutive adult CHD patients operated upon between January 1990 and January 2007 were collected. Categorisation was done according to the EACTS/STS congenital database. Early and late morbidity and mortality were assessed with follow-up extending up to 17 years. EuroSCORE performance was assessed. Results: Nine hundred and sixty-three procedures were performed in 830 patients (mean age 39.3 years, 50.3% male). A total of 49% were re-do procedures, frequent procedures were for left heart lesions (37%), right heart lesions (31%) and septal defects (8%). The 51% primary procedures largely consisted of less complex procedures but also included 1.4% of tetralogy of Fallot repairs, 4.1% of aortic coarctation repairs and 2.7% of Ebstein's disease repairs. Thirty-day mortality was 1.5% (n = 14); predicted mortality by logistic EuroSCORE was 4.6%. c-index was 0.61 (95% CI 0.46-0.75). Major complications such as tamponade requiring intervention occurred in 3.2%, postoperative bleeding requiring re-exploration in 7.1% and renal insufficiency requiring dialysis in 4 (0.4%). Pulmonary hypertension was a strong predictor for short-term mortality; impaired ventricular function and cyanosis for long-term mortality. Overall 17-year survival was 71% (95% CI 61%-82%). Eighty percent of patients were in NYHA class I at last follow-up, 17% in II, 3% in III, 0% in IV. Conclusions: Surgery in adult CHD patients can be performed with low operative mortality and good clinical outcome. EuroSCORE is not a good model for risk assessment in this group of patients. </description>
    </item> <item>
      <title>Clinical outcome 5 to 18 years after the Fontan operation performed on children younger than 5 years (Article)</title>
      <link>http://repub.eur.nl/res/pub/24451/</link>
      <pubDate>2009-07-01T00:00:00Z</pubDate>
      <description>Objective: This study assessed clinical condition at midterm follow-up after total cavopulmonary connection for a functionally univentricular heart performed on children younger than 5 years. Methods: Thirty-four Fontan patients (median age 10.4 years, range 6.8-20.7 years, 22 boys, median follow-up 7.8 years, 5.0-17.8 years) underwent electrocardiography, Holter monitoring, bicycle exercise testing, cardiac magnetic resonance imaging, and N-terminal prohormone brain natriuretic peptide (NT-pro-BNP) analysis. Results: Twenty-three patients (68%) were in sinus rhythm. Holter monitoring demonstrated normal mean heart rate, low maximal heart rate, and no clinically significant arrhythmias or sinus node dysfunction. With maximal bicycle ergometry (n = 19), maximum workload (60% of normal), maximum heart rate (90% of normal), and maximal oxygen uptake (69% of normal) were all significantly lower in the Fontan group than in a control group (P &lt; .001). Variables of submaximal exercise indicated less efficient oxygen uptake during exercise in all Fontan patients. Ejection fraction was lower than in control subjects (59% ± 13% vs 69% ± 5%, P &lt; .001). Mean end-diastolic and end-systolic volumes and ventricular mass were higher than in control subjects (P &lt; .001). Mean NT-pro-BNP levels were increased relative to reference values, but only 8 patients had levels above the upper reference limit. Conclusion: At midterm follow-up, Fontan patients were in acceptable clinical condition, with preserved global ventricular function, moderately decreased exercise capacity, and NT-pro-BNP levels within reference range. Systemic ventricular mass was elevated, however, suggesting contractility-afterload mismatch. Long-term consequences for ventricular function merit further investigation. </description>
    </item> <item>
      <title>Outcome after reoperation for atrioventricular septal defect repair (Article)</title>
      <link>http://repub.eur.nl/res/pub/27259/</link>
      <pubDate>2009-07-01T00:00:00Z</pubDate>
      <description>Results of surgical repair of atrioventricular septal defect (AVSD), both partial (PAVSD) and complete (CAVSD), have improved. However, reoperation is not uncommon. This report describes our experience in 59 patients who underwent reoperation after AVSD repair, between 1977 and 2008. Thirty-one patients had a PAVSD, 28 had a CAVSD. Mean interval between initial repair and reoperation was 10±11 years (PAVSD vs. CAVSD: 13±12 vs. 6±9 years, P=0.063). Reoperations were required for left atrioventricular valve regurgitation (LAVVR) in 53 patients (combined with right atrioventricular valve regurgitation in 10, atrial septal defect (ASD) in 11, ventricular septal defect (VSD) in 7, left ventricular outflow tract (LVOT) obstruction in 1, and aortic valve stenosis in 1), ASD in 3, and LVOT obstruction in 3. Valve repair was performed in 45 patients and replacement in 8. Repair techniques of the leftsided atrioventricular valve (LAVV) included cleft closure in 44 patients, commissuroplasty in 19, and annuloplasty in 1. Freedom from additional reoperation was 85%, and 80% at 5 and 15 years. Hospital mortality was 3%. Overall survival was 91%, and 86% after 5 and 15 years. The most common indication to undergo reoperation is LAVVR. Reoperation is safe and in the majority of cases, a durable repair of the LAVV can still be achieved.</description>
    </item> <item>
      <title>Therapeutic decisions for patients with symptomatic severe aortic stenosis: room for improvement? (Article)</title>
      <link>http://repub.eur.nl/res/pub/24344/</link>
      <pubDate>2009-06-01T00:00:00Z</pubDate>
      <description>Objective: Symptomatic severe aortic stenosis is an indication for aortic valve replacement. Some patients are denied intervention. This study provides insight into the proportion of conservatively treated patients and into the reasons why conservative treatment is chosen. Methods: Of a patient cohort presenting with severe aortic stenosis between 2004 and 2007, medical records were retrospectively analyzed. Only symptomatic patients (n = 179) were included. We studied their characteristics, treatment decisions, and survival. Results: Mean age was 71 years, 50% were male. During follow-up (mean 17 months, 99% complete) 76 (42%) patients were scheduled for surgical treatment (63 conventional valve replacement, 10 transcatheter, 1 heart transplantation, 2 waiting list) versus 101 (56%) who received medical treatment. Reasons for medical treatment were: perceived high operative risk (34%), symptoms regarded mild (19%), stenosis perceived non-severe (14%), and patient preference (9%). In 5% the decision was pending at the time of the analysis and in 20% the reason was other/unclear. Mean age of the surgical group was 68 years versus 73 years for medically treated patients (p = 0.004). Predicted mortality (EuroSCORE) was 7.8% versus 11.3% (p = 0.006). During follow-up 12 patients died in the surgical group (no 30-day operative mortality), versus 28 in the medical group. Two-year survival was 90% versus 69%. Conclusions: A large proportion (56%) of symptomatic patients does not undergo aortic valve replacement. Often operative risk is estimated (too) high or hemodynamic severity and symptomatic status are misclassified. Interdisciplinary team discussions between cardiologists and surgeons should be encouraged to optimize patient selection for surgery. </description>
    </item> <item>
      <title>Pulmonary vein and atrial wall pathology in human total anomalous pulmonary venous connection (Article)</title>
      <link>http://repub.eur.nl/res/pub/24386/</link>
      <pubDate>2009-05-29T00:00:00Z</pubDate>
      <description>Background: Normally, the inside of the left atrial (LA) body and pulmonary veins (PVs) is lined by vessel wall tissue covered by myocardium. In total anomalous pulmonary venous connection (TAPVC), no connection of the PVs with the LA body exists. These veins have an increased incidence of PV stenosis. We describe the consequences of the absent connection for the histopathology of the wall of the LA body and the PVs, and hypothesize on a mechanism predisposing to PV stenosis. Methods and results: In 10 human neonates with TAPVC, the wall of the LA body and PVs were studied using histological and immunohistochemical techniques. As controls, 2 normal neonatal and adult hearts and 5 neonatal hearts with partial anomalous venous connection (PAPVC) or situs inversus were studied. In hearts with TAPVC no vessel wall tissue was found in the LA body and its myocardial layer was hypoplastic. No myocardial sleeve was found around the abnormally draining PVs. In hearts with PAPVC, only the non-LA draining PV lacked myocardial covering, whereas in situs inversus PVs connecting to the right-sided LA, were normally myocardialized. Conclusion: An open connection of the PVs with the morphological LA is necessary for the presence of vessel wall tissue in the LA and myocardialization of the PVs. Absence of myocardium covering the PVs is hypothesized to enhance susceptibility to PV stenosis and prevent onset of PV originating arrhythmias. The embryonic posterior heart field may be responsible for the abnormal myocardialization and smooth muscle cell formation in TAPVC. </description>
    </item> <item>
      <title>Risk factors for low colloid osmotic pressure during infant cardiopulmonary bypass with a colloidal prime (Article)</title>
      <link>http://repub.eur.nl/res/pub/16525/</link>
      <pubDate>2009-05-01T00:00:00Z</pubDate>
      <description>Extensive variations of colloid osmotic pressure (COP) measured in the priming as well as during infant cardiopulmonary bypass motivated us to audit clinical and laboratory data to identify the risk factors for low COP at the end of bypass. Data of 73 consecutive infant patients with body weight &lt;10 kg, who underwent elective, first time open-heart surgery between March 2005 and December 2006 were examined. The following variables were analyzed: COP, blood loss, transfusion requirements and hematological data. Univariate and multivariate analysis of risk factors for low COP (&lt;15 mmHg) was performed. Forty-eight percent of patients had COP &lt;15 mmHg at the end of bypass. Those patients had significantly lower COP before start of bypass, during, and at the end of the operation. Significant univariate predictors of low COP at the end of bypass were: lower patient weight; lower COP before start of bypass, lower priming COP and larger volume of cardioplegia received into the circulation. After multivariable analysis, lower patient COP before bypass remained the only significant predictor for low COP at the end of bypass. Pre-bypass crystalloid dilution during induction should be avoided, as this is the most important cause of low COP during the bypass. Priming COP and COP management strategy should be adapted to the individual patient demand.</description>
    </item> <item>
      <title>Three-dimensional transesophageal echocardiography: Diagnosing the extent of pericarditis constrictiva and intraoperative surgical support (Article)</title>
      <link>http://repub.eur.nl/res/pub/24851/</link>
      <pubDate>2009-05-01T00:00:00Z</pubDate>
      <description>The traditional two-dimensional transthoracic echocardiography (2DTTE) has limitations in demonstrating the extent of pericardial thickening in constrictive pericarditis (CP) because of poor transmission of ultrasound through the thickened anterior pericardial structures. We describe a case of CP, of unknown etiology, in which transesophageal 3DTEE equalled the accuracy of cardiac magnetic resonance in demonstrating the extent of pericardial thickening in CP. </description>
    </item> <item>
      <title>Image quality using a micromultiplane transesophageal echocardiography probe in older children during cardiac surgery (Article)</title>
      <link>http://repub.eur.nl/res/pub/27125/</link>
      <pubDate>2009-05-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Assessment of biventricular functional reserve and NT-proBNP levels in patients with RV volume overload after repair of tetralogy of Fallot at young age (Article)</title>
      <link>http://repub.eur.nl/res/pub/24381/</link>
      <pubDate>2009-04-17T00:00:00Z</pubDate>
      <description>Purpose: To assess biventricular functional reserve (FR), NT-proBNP levels and exercise performance, in relation to right ventricular volume in patients with pulmonary regurgitation (PR) after repair of tetralogy of Fallot (TOF) at young age. Methods: In 53 TOF patients (maximum age at repair 2.0 years, interval since repair 15 (5) years) without residual lesions except PR, biventricular FR (derived from magnetic resonance imaging with dobutamine stress), NT-proBNP levels, maximal workload, and peak oxygen uptake were assessed. Results: Mean right ventricular end-diastolic volume was 140(38) ml/m2. Median pulmonary regurgitant fraction was 37% (range 0-57%). Biventricular systolic stress response was normal: mean (SD) ESV decreased (ΔRVESV - 17(8) ml/m2, ΔLVESV - 11(5)), SV increased (ΔRVSV + 12(9) ml/m2, ΔLVSV + 9(6)), FR was positive in all (RV-FR + 11(5)%, LV-FR + 13(6)). No serious adverse effects to dobutamine were encountered. NT-proBNP was increased in 2 patients. Median level was 10 pmol/L (range 2-42). NT-proBNP correlated with PR-percentage but not with right ventricular size. High-risk levels of NT-proBNP indicated a smaller RV-FR and a smaller decrease of biventricular ESV. Mean (SEM) VO2maxwas 96(3)%, mean Workloadmax89(2)% of predicted. Conclusion: At mid to long term follow-up overall NT-proBNP levels are normal and biventricular functional reserve and exercise tolerance are well preserved in TOF repaired at young age, irrespective of RV volume. This questions the validity of isolated PR or RV volume criteria for pulmonary valve replacement in this group. Low-dose dobutamine stress testing is well tolerated and may be a useful additional tool for clinical decision making. </description>
    </item> <item>
      <title>Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: Weighing lifetime anticoagulant-related event risk against reoperation risk (Article)</title>
      <link>http://repub.eur.nl/res/pub/16571/</link>
      <pubDate>2009-04-01T00:00:00Z</pubDate>
      <description>Objective: Although the results of aortic valve replacement with different valve prostheses are well documented in terms of survival, the risks of (valve-related) events are less well explored. Methods: We used a dataset of 3934 patients who underwent aortic valve replacement with either a bioprosthesis (73%) or a mechanical prosthesis (27%) between 1982 and 2003 to simulate the outcome of patients after aortic valve replacement with either valve type. With the use of microsimulation, we compared total age and gender-specific life expectancy, event-free life expectancy, reoperation-free life expectancy, lifetime risks of reoperation, and valve-related events for both valve types. Results: The total follow-up was 26,467 patient-years. The mean follow-up was 6.1 years in the biological arm and 8.5 years in the mechanical arm. The mean age at implantation was 70 and 58 years for biological and mechanical prostheses, respectively, and the percentage of concomitant coronary artery bypass grafting was 47% and 28%, respectively. For a 60-year-old man, simulated life expectancy in years for biological versus mechanical prostheses was 11.9 versus 12.2, event-free life expectancy was 9.8 versus 9.3, and reoperation-free life expectancy was 10.5 versus 11.9. Lifetime risk of reoperation was 25% versus 3%. Lifetime risk of bleeding was 12% versus 41%. Conclusion: Even for patients aged 60 years, event-free life expectancy is better with a bioprosthesis. Although the chance of reoperation is higher, the lifetime risk of bleeding is lower compared with a mechanical prosthesis. Comparing lifetime event risks between different types of valve prostheses provides more insight into patient outcome after aortic valve replacement and aids patient selection and counseling.</description>
    </item> <item>
      <title>Complexity of Coronary Vasculature Predicts Outcome of Surgery for Left Main Disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/24279/</link>
      <pubDate>2009-04-01T00:00:00Z</pubDate>
      <description>Background: The SYNTAX score, a comprehensive angiographic scoring system, was recently developed as a tool for risk stratification during the SYNTAX trial (randomized trial comparing coronary artery bypass grafting with percutaneous coronary intervention). We applied the SYNTAX score in patients with left main coronary artery disease who underwent coronary artery bypass grafting to examine its role in predicting incidences of major adverse cardiac and cerebrovascular events (MACCE) within 30 days and 1 year. Methods: One hundred forty-eight patients were studied. Their angiograms were scored according to the SYNTAX score. The MACCE-free survival curves were estimated by the Kaplan-Meier method. Univariate and multivariate analyses determined risk factors for MACCE. Performance of the SYNTAX score was studied with respect to discrimination by receiver-operating characteristic curves with their area under the curve (c-index). Classification and regression tree analysis was performed to identify the best outcome predictors and develop a risk stratification model. Results: Overall SYNTAX score ranged from 11 to 53 (mean, 24 ± 9). At 30 days and 1 year, 15 (10%) and 19 (13%) patients experienced MACCE. Patients with a higher SYNTAX score had a significantly (p &lt; 0.0001) poorer MACCE-free survival. In multivariate analysis, SYNTAX score, female sex, and incomplete revascularization were associated with a higher rate of MACCE in 30 days. The SYNTAX score was the single predictor for MACCE in 1 year. The c-index of the SYNTAX score was 0.88 for 30 days and 0.90 for 1 year, respectively. The SYNTAX score was the best single discriminator between patients with and those without MACCE, with a discrimination level of 36.5. Conclusions: The SYNTAX score is the first coronary vasculature complexity score predictive for postoperative outcome in patients with left main coronary artery disease undergoing coronary artery bypass grafting. The outcomes of the ongoing SYNTAX trial will definitively define the role of the SYNTAX score in predicting short-term and long-term incidence of MACCE. </description>
    </item> <item>
      <title>Intraoperative transesophageal echocardiography is beneficial for hemodynamic stabilization during left ventricular assist device implantation in children (Article)</title>
      <link>http://repub.eur.nl/res/pub/24805/</link>
      <pubDate>2009-04-01T00:00:00Z</pubDate>
      <description>Background: Mechanical circulatory support, with a left ventricular assist device (LVAD) is used in an increasing number of children for treatment of advanced heart failure as bridge-to-transplant. To date no data are available and no studies have defined the role of intraoperative transesophageal echocardiography (TEE) for hemodynamic stabilization during Centrimag Levitronix centrifugal pump implantation in children. Methods: Children with therapy resistant heart failure, undergoing LVAD implantation using Berlin Heart Excor pediatric cannula connected to a Levitronix Centrifumag pump, are intraoperatively monitored using an Oldelft micromultiplane TEE. Intraoperative TEE is specially used to monitor right ventricular (RV) and left ventricular (LV) function, correct position of the cannulas and response to pharmacological treatment. Results: In five consecutive patients RV function was assessed by TEE after starting LVAD Levitronix centrifugal pump. Initial RV failure presents with RV dilation and LV collapse. After titration of vasopressor and inotropic agents, RV contractility improved and thereby the filling of the LV. In one child, despite those measures the RV showed no improvement by TEE and a Levitronix right ventricular assist device to support the RV function was implanted as well. All patients could hemodynamically be stabilized before transport to the intensive care unit. Conclusion: The complex interaction of the RV and LV function and correct positioning of the cannula, during LVAD implantation in children with end-stage cardiac failure is improved by simultaneous visualization of cardiac performance of both ventricles and cannula positioning by means of intraoperative multiplane TEE. </description>
    </item> <item>
      <title>Intraoperative Graft Patency Verification in Coronary Artery Surgery: Modern Diagnostic Tools (Article)</title>
      <link>http://repub.eur.nl/res/pub/27070/</link>
      <pubDate>2009-04-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Screening methods for delirium: Early diagnosis by means of objective quantification of motor activity patterns using wrist-actigraphy (Article)</title>
      <link>http://repub.eur.nl/res/pub/18232/</link>
      <pubDate>2009-03-01T00:00:00Z</pubDate>
      <description>Delirium after cardiac surgery is a risk factor for adverse outcome and even death. Disturbance of motor activity is a core feature of delirium, but hypoactive delirium often remains unrecognized. We explored wrist-actigraphy as a tool to objectively quantify postoperative recovery of 24-h rest-activity patterns to improve the early recognition of delirium after surgery. Motor activity was recorded by wristactigraphy after cardiac surgery in 88 patients over 65 years of age. Patients were assessed daily by using the CAM-ICU. Our final analyses were based on 32 non-delirious patients and 38 patients who were delirious on the first day after surgery. The delirious patients showed lower mean activity levels during the first postoperative night (P&lt;0.05), reduced restlessness during the first day (P&lt;0.05), and a lower mean activity of the 5 h with lowest activity within the first 24 h (P=0.01), as compared to the non-delirious patients. Already at a very early stage after cardiac surgery, a difference in motor activity was observed between patients with and without a delirium. As an unobtrusive method, actigraphy has the potential to be a screening method that may lead to early diagnosis and treatment of delirium.</description>
    </item> <item>
      <title>Disturbed circadian motor activity patterns in postcardiotomy delirium (Article)</title>
      <link>http://repub.eur.nl/res/pub/14958/</link>
      <pubDate>2009-02-01T00:00:00Z</pubDate>
      <description>Aims: More than 20% of patients of 65 years or older may develop a delirium after cardiac surgery. Patients with delirium frequently show a disturbed 24-hr motor activity pattern, but objective and quantitative data are scarce. Our aim was to quantify motor activity patterns in elderly patients with or without a postcardiotomy delirium after elective cardiac surgery. Methods: Wrist-actigraphy was used to quantify 24-hr motor activity patterns for a 5-day period following cardiac surgery in 79 patients of 65 years or older. Clinical state was monitored daily by means of the Confusion Assessment Method-Intensive Care Unit and the Delirium Rating Scale-Revised 98. Results: The activity Amplitude, and the daytime Activity/minute and Restlessness index were significantly higher and the daytime number of Immobility minutes significantly lower for the patients without delirium or with short delirium episodes, as compared to patients with a sustained delirium (&gt;3 days). Conclusions: Actigraphy proves to be a valuable instrument for evaluating motor activity patterns in relation to clinical state in patients with a postcardiotomy delirium.</description>
    </item> <item>
      <title>Surfactant pretreatment decreases long-term damage after ischemia-reperfusion injury of the lung (Article)</title>
      <link>http://repub.eur.nl/res/pub/24342/</link>
      <pubDate>2009-02-01T00:00:00Z</pubDate>
      <description>Objective: Lung ischemia-reperfusion injury (LIRI) is a risk factor for primary acute graft failure following lung transplantation. LIRI hereby contributes to morbidity and mortality after lung transplantation. We have previously shown that surfactant pretreatment ameliorates LIRI up to 1 week after reperfusion. However, the impact of surfactant pretreatment on long-term outcome following LIRI is unknown. Therefore, the objective of this study was to investigate the effect of surfactant pretreatment on long-term outcome following LIRI. Methods: Male Sprague-Dawley rats (n = 63) were randomized to receive intratracheally administered porcine surfactant (400 mg/kg) or no pretreatment. One hour thereafter, animals underwent 120 min of warm ischemia by clamping the bronchus, pulmonary artery and vein of the left lung. A third group was sham-operated; a fourth group served as unoperated controls. Animals were killed on day 30 or 90 after surgery. Arterial oxygenation and lung compliance were determined. Broncho-alveolar lavage fluid (BALf) was collected to assess surfactant function and alveolar protein. Leukocyte infiltration was determined by flowcytometry in BALf, lung tissue and thoracic lymph nodes. Lungs of three animals per group were used for histological assessment. Results: Lung compliance was lower on day 30 and day 90 after LIRI than in sham-operated controls (day 30 Vmax6.1 ± 2.1 vs 12.6 ± 1.3, day 90 6.9 ± 3.0 vs 12.1 ± 1.6; Cmaxday 30 0.49 ± 0.17 vs 1.08 ± 0.21, day 90 0.67 ± 0.31 vs 1.11 ± 0.17). Furthermore, the number of CD45RA+-lymphocytes in left lung tissue was decreased on day 90 compared to unoperated animals (230.633 ± 96.770 vs 696.347 ± 202.909) and the number of macrophages elevated in left BALf on day 90. HE slides of LIRI animals were scored as fibroproliferative with moderate atelectasis. Surfactant pretreatment improved lung compliance (Vmaxday 30 11.7 ± 1.8, day 90 11.1 ± 1.2; Cmaxday 30 1.04 ± 0.23, day 90 1.16 ± 0.21) and normalized the number of CD45RA+-lymphocytes (769.555 ± 421.016) in left lung tissue. Furthermore lung architecture on HE slides was on return to normal. However, more CD5+CD4+-lymphocytes on day 30 (754.788 ± 97.269 vs 430.409 ± 109.909) and more macrophages on day 90 (2.144.000 ± 630.633 vs 867.454 ± 383.220) were measured in pretreated lung tissue compared to LIRI animals. Conclusions: Severe LIRI caused extensive pulmonary injury up to 90 days postoperatively. Surfactant pretreatment normalized pulmonary function, but resulted in an increased number of CD5+CD4+-cells and macrophages in lung tissue. </description>
    </item> <item>
      <title>The clinical outcome after coronary bypass surgery: A 30-year follow-up study (Article)</title>
      <link>http://repub.eur.nl/res/pub/27091/</link>
      <pubDate>2009-02-01T00:00:00Z</pubDate>
      <description>Aims: To investigate the long-term clinical outcome (up to 30 years) after coronary artery bypass graft (CABG) surgery and to assess the life expectancy (LE) among subgroups of patients. Methods and results: We analysed the 30-year outcome of the first 1041 consecutive patients in our institution (age at operation 53 years, 88% male) who underwent venous CABG between 1971 and 1980. During follow-up, every 5-7 years follow-up status was obtained by reviewing the hospital records and from general practitioners and civil registries. Data were collected on death and repeat coronary revascularization procedures. Follow-up was complete in 98%. Median follow-up was 29 years (26-36 years). The cumulative 10-, 20-, and 30-year survival rates were 77%, 40%, and 15%, respectively. Overall, 623 coronary re-interventions were performed in 373 patients (36%). The cumulative 10-, 20-, and 30-year freedom from death and coronary re-intervention rates were 60%, 20%, and 6%, respectively. Age [hazard ratio (HR) 1.04/year], extent of vessel disease (VD) (two-VD HR 1.4; three-VD HR 1.9), left main disease (HR 1.6) and impaired left ventricular ejection fraction (LVEF) (HR 1.8) were independent predictors of mortality. We were able to assess the exact LE by calculating the area under the Kaplan-Meier curves. Overall LE after first CABG was 17.6 years. LE in patients with one-, two-, and three-VD was 21.4, 18.8, and 15.4 years, respectively (P &lt; 0.0001). Patients with impaired LVEF had a significant shorter LE than patients with normal LVEF (13.9% vs. 19.3%; P &lt; 0.0001). Conclusion: This 30-year follow-up study comprises the almost complete life cycle after CABG surgery. Overall median LE was 17.6 years. As the majority of the patients (94%) needed a repeat intervention, we conclude that the classic venous bypass technique is a useful but palliative treatment of a progressive disease. </description>
    </item> <item>
      <title>The Ross procedure: A systematic review and meta-analysis (Article)</title>
      <link>http://repub.eur.nl/res/pub/19343/</link>
      <pubDate>2009-01-20T00:00:00Z</pubDate>
      <description>Background - Reports on outcome after the Ross procedure are limited by small study size and show variable durability results. A systematic review of evidence on outcome after the Ross procedure may improve insight into outcome and potential determinants. Methods and Results - A systematic review of reports published from January 2000 to January 2008 on outcome after the Ross procedure was undertaken. Thirty-nine articles meeting the inclusion criteria were allocated to 3 categories: (1) consecutive series, (2) adult patient series, and (3) pediatric patient series. With the use of an inverse variance approach, pooled morbidity and mortality rates were obtained. Pooled early mortality for consecutive, adult, and pediatric patients series was 3.0% (95% confidence interval [CI], 1.8 to 4.9), 3.2% (95% CI, 1.5 to 6.6), and 4.2% (95% CI, 1.4 to 11.5). Autograft deterioration rates were 1.15% (95% CI, 1.06 to 2.06), 0.78% (95% CI, 0.43 to 1.40), and 1.38%/patient-year (95% CI, 0.68 to 2.80), respectively, and for right ventricular outflow tract conduit were 0.91% (95% CI, 0.56 to 1.47), 0.55% (95% CI, 0.26 to 1.17), and 1.60%/patient-year (95% CI, 0.84 to 3.05), respectively. For studies with mean patient age &gt;18 years versus mean patient age ≤ 18 years, pooled autograft and right ventricular outflow tract deterioration rates were 1.14% (95% CI, 0.83 to 1.57) versus 1.69% (95% CI, 1.02 to 2.79) and 0.65% (95% CI, 0.41 to 1.02) versus 1.66%/patient-year (95% CI, 0.98 to 2.82), respectively. Conclusions - The Ross procedure provides satisfactory results for both children and young adults. Durability limitations become apparent by the end of the first postoperative decade, in particular in younger patients.</description>
    </item> <item>
      <title>Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: Implications for dilated cardiomyopathy (Article)</title>
      <link>http://repub.eur.nl/res/pub/25042/</link>
      <pubDate>2009-01-09T00:00:00Z</pubDate>
      <description>Background: Dysregulation of dendritic cell (DC) mediated immune responses towards auto-antigens, is considered an important feature in the maintenance of experimentally induced heart failure (HF). In order to evaluate the role of blood DCs in cardiomyopathies of different origins, we examined myeloid (mDC) and plasmacytoid (pDC) subset levels and maturation characteristics, according to HF severity and etiology in humans. Methods: Absolute numbers of mDCs and pDCs in 12 New York Heart Association (NYHA) class-II, 28 NYHA class III-IV HF patients and 18 healthy controls, were studied by 4-colour whole blood flow cytometry. Results: End-stage (NYHA III-IV) HF patients had comparable circulating DC subset levels to NYHA-II patients and controls. However, within the NYHA III-IV group total DC levels in patients with non-ischemic dilated cardiomyopathy (DCM) were higher (P &lt; 0.001) than in patients with coronary artery disease (CAD), hypertrophic cardiomyopathy (HCM) or other HF etiology. This was due to a significant increase of primarily mDCs (P &lt; 0.0001) and to a lesser extent of pDCs (P &lt; 0.05) in idiopathic DCM patients, independent of systolic or diastolic cardiac dysfunction. Maturation marker CD83 and lymphoid homing chemokine receptor CCR7 surface expression was enhanced only on mDCs, but not pDCs from DCM patients (P &lt; 0.05), compared to patients with CAD, HCM or other underlying cardiac pathophysiology. Conclusions: Total blood DC levels in end-stage HF are elevated in patients with DCM. Whole blood DC characterisation may lead to new insights into the pathophysiology of idiopathic DCM in humans. </description>
    </item> <item>
      <title>Microbiological examination of donated human cardiac tissue in heart valve banking (Article)</title>
      <link>http://repub.eur.nl/res/pub/17040/</link>
      <pubDate>2009-01-01T00:00:00Z</pubDate>
      <description>Objective: Microbiological examination of donated human cardiac tissue is a necessary procedure for Heart Valve Banks to determine the biological safety of preserved allografts. Test protocols must be validated to prevent false-negative outcomes that pose a risk of infection to recipients of the tissue. The Heart Valve Bank in Rotterdam evaluated a validated, alternative entry test for donated tissues to compare the performance of its standard microbiological examinations. Methods: Samples of explanted heart transport medium from 275 donors were examined for the presence of microorganisms using blood culture flasks (standard test) and fluid thioglycolate medium (alternative test). Results were compared with the outcome of microbiological assessment of subvalvular myocardial fragments and the cryoprotective medium that were collected before and after treatment of the grafts with antibiotics, respectively. Results: Microorganisms, mainly skin flora, were detected in transport medium of 177 hearts (64%). The alternative validated culture method detected a growth in 80 transport medium samples that was not identified by the standard method. Microorganisms were only identified in the cultivated cardiac tissue fragments from 56 donors (20%). After antibiotic treatment of the tissue, microorganisms could still be encountered in cryoprotective medium samples from 55 donors (20%). Most of the contaminants in these final samples were identified as Propionibacterium species and Corynebacterium species and had already been detected in the transport medium by the alternative validated culture method. Conclusions: The use of blood culture flasks for microbiological assessment of non-blood liquid media and the cultivation of myocardial tissue fragments may hamper detection of certain microorganisms and therefore provide less complete information about microbiological safety. Heart Valve Banks may want to review their microbiological examination and decontamination procedures regarding the ability to detect and eliminate anaerobic skin flora, respectively.</description>
    </item> <item>
      <title>Invited Commentary (Article)</title>
      <link>http://repub.eur.nl/res/pub/26980/</link>
      <pubDate>2009-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Invited Commentary (Article)</title>
      <link>http://repub.eur.nl/res/pub/28805/</link>
      <pubDate>2008-12-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Long-term intellectual functioning and school-related behavioural outcomes in children and adolescents after invasive treatment for congenital heart disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/29541/</link>
      <pubDate>2008-11-01T00:00:00Z</pubDate>
      <description>In this study, long-term intellectual functioning and school-related behavioural outcomes were assessed in a patient sample that underwent invasive treatment for congenital heart disease (ConHD) between 1990 and 1995. The Wechsler Intelligence Scale for Children-Revised was used to measure intellectual functioning and the Teacher's Report Form to assess teacher-reported behavioural and emotional problems. Overall, patients had IQ scores that fell within the normal range. The total sample of ConHD children (N=117, 7-16 years old), however, obtained significantly lower mean scores on Verbal IQ and Verbal Comprehension than reference children. When compared with same-aged reference peers from the general population, 7-11-year-old ConHD children obtained significantly lower mean scores on Total IQ, Verbal IQ, Verbal Comprehension, and Perceptual Organization. In contrast, scores of 12-16-year-old ConHD children appeared to be significantly lower on Verbal Comprehension only and significantly higher on Performance IQ. No significant differences were found in intellectual functioning between ConHD boys and girls, nor between different diagnostic groups. The school-related behavioural and emotional adjustment of this sample of children with treated ConHD was favourable. Overall, this sample of recently treated ConHD children, and especially children aged 7-11 years, showed poorer intellectual functioning in several areas. These findings deserve further attention. </description>
    </item> <item>
      <title>Usefulness of intraoperative real-time 3D transesophageal echocardiography in cardiac surgery (Article)</title>
      <link>http://repub.eur.nl/res/pub/29832/</link>
      <pubDate>2008-11-01T00:00:00Z</pubDate>
      <description>Background: Recent advances in three-dimensional (3D) echocardiography allow to obtain real-time 3D transesophageal (RT3DTEE) images intraoperatively. Methods: Preoperative transthoral echocardiography (TTE) revealed: hypertrophic ventricular septum (TTE:19.3 mm), systolic anterior motion (SAM) not causing obstruction and malcoaptation of the anterior mitral valve leaflet (AMVL), and posterior mitral valve leaflet (PMVL) with severe mitral regurgitation. Results: Intraoperative TEE with a x7-2t MATRIX-array transducer (Philips, Andover, MA, USA) with a transducer frequency of x7-2 t mHz, connected to a iE33 (Philips), shows us that the main mechanism and site of regurgitation was an AMVL cleft. We also measured a 24.3-mm thickness of the ventricular septum and analyzing the 3D full volume acquisition revealed that there was no SAM. Conclusion: Intraoperative RT3DTEE permitted comprehensive 3D viewing of the mitral valve revealing the mechanism of mitral valve regurgitation, SAM, and the exact width of the hypertrophic ventricular septum. </description>
    </item> <item>
      <title>Pulmonary artery size and function after fontan operation at a young age (Article)</title>
      <link>http://repub.eur.nl/res/pub/30112/</link>
      <pubDate>2008-11-01T00:00:00Z</pubDate>
      <description>Purpose: To assess pulmonary artery (PA) size, flow variables, and wall shear stress (WSS) in patients after Fontan operation at a young age. Materials and Methods: Flow in the branch PA was obtained with phase contrast velocity-encoded cardiovascular magnetic resonance imaging in 14 patients before and after low-dose dobutamine stress (7.5 μg/kg/min) and in 17 healthy controls at rest. Results: At rest, stroke index, total flow, average, and peak flow rate were all statistically significantly lower in patients than in controls (P &lt; 0.001). With stress-testing, all variables increased in patients (P &lt; 0.001), apart from stroke index, which did not change. At rest, branch PA area did not differ between patients and controls. Distensibility was lower in patients than in controls (P &lt; 0.001). With stress-testing, area and distensibility did not change. At rest, WSS was lower in patients than in controls (P &lt; 0.001). WSS increased with stress-testing (P &lt; 0.001), but not to the same levels as during resting conditions of the control group. Conclusion: PA size is normal long-term after Fontan operation at a young age. Flow variables, distensibility, and WSS are significantly lower compared to healthy controls, and do not show adequate reactions with stress-testing, which is suggestive of pulmonary artery endothelial and/or vascular dysfunction. </description>
    </item> <item>
      <title>Is the Ross procedure really a Trojan horse: Reply (Article)</title>
      <link>http://repub.eur.nl/res/pub/15204/</link>
      <pubDate>2008-09-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Three life-years gained from smoking cessation after coronary artery bypass surgery: A 30-year follow-up study (Article)</title>
      <link>http://repub.eur.nl/res/pub/29005/</link>
      <pubDate>2008-09-01T00:00:00Z</pubDate>
      <description>Background: Previous studies have shown that smoking cessation after a cardiac event reduces the risk of subsequent mortality in patients, but the effect of smoking cessation in terms of prolonged life-years is not yet known. Methods: We analyzed the 30-year clinical outcome of the first 1,041 consecutive patients (age at operation 51 years, 92% male) who successfully underwent isolated venous coronary artery bypass surgery between 1971 and 1980. All 551 smokers (53%) were included in this study. Of these, 43% stopped smoking throughout the first year whereas 57% persisted smoking. Results: The median follow-up was 29 years (range 26-36 years). The cumulative 10-, 20-, and 30-year survival rates were 88%, 49%, and 19%, respectively, in the group of patients who quit smoking, and only 77%, 36%, and 11%, respectively, in the persistent smokers (P &lt; .0001). After adjusting for all baseline characteristics, smoking cessation remained an independent predictor of lower mortality (hazard ratio 0.60, 95% CI 0.48-0.72). We were able to assess the exact life expectancy by calculating the area under the Kaplan-Meier curves. Life expectancy in the quitters was 20.0 years and 17.0 years in the persistent smokers (P &lt; .0001). Conclusions: Using 30-year follow-up data, we estimated that self-reported smoking cessation after coronary artery bypass surgery was associated with a life expectancy gain of 3 years. Smoking cessation turned out to have a greater effect on reducing the risk of mortality than the effect of any other intervention or treatment. </description>
    </item> <item>
      <title>Follow-up outcomes 10 years after arterial switch operation for transposition of the great arteries: Comparison of cardiological health status and health-related quality of life to those of the a normal reference population (Article)</title>
      <link>http://repub.eur.nl/res/pub/29734/</link>
      <pubDate>2008-09-01T00:00:00Z</pubDate>
      <description>The purpose of this study was to investigate the cardiological health status and health-related quality of life after the arterial switch operation (ASO) for transposition of the great arteries (TGA) in comparison with a normative reference group. Chart review and cross-sectional systematic follow-up, including echocardiography, exercise testing, and electrocardiography, were performed on all survivors of ASO for TGA between 1990 and 1995. Health-related quality of life (HRQOL) was assessed using a standardized questionnaire. A normative reference group was included. Forty-nine survivors [median age at operation 13 days, mean age at follow-up 11±2 years (37/49 with intact ventricular septum] were identified. Thirty-three of 49 patients (67%) [22/33 TGA with intact ventricular septum (IVS)] participated in cross-sectional follow-up. Cumulative 10-year event-free survival was 88% and the re-intervention rate 6%. Aortic root dilatation occurred in 70% of patients; none had severe aortic regurgitation. Left ventricular function was normal. Exercise performance (85% of reference capacity, p=0.02), maximal oxygen uptake (85%, p&lt;0.01) and peak heart rate (95%, p&lt;0.01) were decreased. Exercise electrocardiogram was normal as was rhythm status. Unfavourable outcomes on HRQOL were found for motor functioning and positive emotional functioning. Overall there were no significant differences between TGA/IVS and TGA/VSD. We conclude that at mid- to long-term follow-up after ASO, major events and re-interventions (6%) occur infrequently. Exercise capacity and maximal oxygen uptake are lower than those in a reference population, which could not be related to diminished ventricular function. Aortic root dilatation is frequent, irrespective of the anatomical subgroup. Severe aortic regurgitation or left ventricular dilatation was not found. The unfavourable health-related quality of life deserves further attention. </description>
    </item> <item>
      <title>Periostin expression by epicardium-derived cells is involved in the development of the atrioventricular valves and fibrous heart skeleton (Article)</title>
      <link>http://repub.eur.nl/res/pub/29741/</link>
      <pubDate>2008-09-01T00:00:00Z</pubDate>
      <description>The epicardium is embryologically formed by outgrowth of proepicardial cells over the naked heart tube. Epicardium-derived cells (EPDCs) migrate into the myocardium, contributing to myocardial architecture, valve development, and the coronary vasculature. Defective EPDC formation causes valve malformations, myocardial thinning, and coronary defects. In the atrioventricular (AV) valves and the fibrous heart skeleton isolating atrial from ventricular myocardium, EPDCs colocalize with periostin, a matrix molecule involved in remodeling. We investigated whether proepicardial outgrowth inhibition affected periostin expression and how this related to development of the AV valves and fibrous heart skeleton. Periostin expression by epicardium and EPDCs was confirmed in vitro in primary cultures of human and quail EPDCs. Disturbing EPDC formation in quail embryos reduced periostin expression in the endocardial cushions and AV junction. Disturbed fibrous tissue development resulted in AV myocardial connections reflected by preexcitation electrocardiographic patterns. We conclude that EPDCs are local producers of periostin. Disturbance of EPDC formation results in decreased cardiac periostin levels and hampers the development of fibrous tissue in AV junction and the developing AV valves. The resulting cardiac anomalies might link to Wolff-Parkinson White syndrome with persistent AV myocardial connections. </description>
    </item> <item>
      <title>Management of elderly patients with aortic valve disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/30508/</link>
      <pubDate>2008-08-12T00:00:00Z</pubDate>
      <description>Increased life expectancy has resulted in a growing population of elderly people, among whom aortic stenosis is increasingly prevalent. For the majority of patients, the treatment of aortic stenosis is surgical, and every symptomatic patient should be considered for aortic valve replacement. Although operative mortality seems to be declining over time, a substantial number of patients do not undergo surgery because of excessive risk, advanced age, or treatment preference of either the patient or the physician. The challenge in the near future will be the enhancement of tools for proper clinical decision-making, so that patients can be stratified to appropriate treatment alternatives. Reports on the treatment of aortic valve stenosis should, therefore, include all patients presenting with the disease and not only those who receive surgery.</description>
    </item> <item>
      <title>Intraoperative cell salvage in infants undergoing elective cardiac surgery: a prospective trial (Article)</title>
      <link>http://repub.eur.nl/res/pub/30104/</link>
      <pubDate>2008-08-01T00:00:00Z</pubDate>
      <description>Background: For a long time intraoperative cell salvage was considered not to be applicable in paediatric patients due to technical limitations. Recently, new autotransfusion devices with small volume centrifugal bowls and dedicated paediatric systems allow efficient blood salvage in small children. The purpose of this prospective non-randomised study was to determine the impact of intraoperative cell salvage on postoperative allogeneic blood products transfusion in infant patients undergoing cardiac surgery with cardiopulmonary bypass. Methods: Two consecutive cohorts (122 patients) were studied. The first cohort underwent procedures between January 2004 and July 2005 with only blood salvage from the residual volume. The second cohort consisted of patients operated on from August 2005 to December 2006, with additional use of intraoperative cell salvage. The following variables were analysed: peri- and postoperative blood loss, transfusion of homologous blood products and cell salvage product, haematological and coagulation data, measured before, during and after the operation. Results: Additional intraoperative cell salvage significantly enhanced the amount of cell saving product available for transfusion (183 ± 56 ml vs 152 ± 57 ml, p = 0.003) and significantly more patients in this group received the cell saving product postoperatively. Consequently, allogeneic blood transfusion was significantly reduced in volume as well as in frequency. We did not observe any adverse effects of intraoperative cell salvage. Conclusion: Intraoperative cell salvage, employed as an adjuvant technique to the residual volume salvage in infants undergoing first time cardiac surgery with cardiopulmonary bypass, was a safe and effective method to reduce postoperative allogeneic blood transfusion. Considering current cell salvage related expense and the cost reduction achieved by diminished allogeneic transfusion, intraoperative cell salvage in infants demonstrated no economic benefit. </description>
    </item> <item>
      <title>Epicardial coronary artery Doppler: Validation in the animal model (Article)</title>
      <link>http://repub.eur.nl/res/pub/30452/</link>
      <pubDate>2008-08-01T00:00:00Z</pubDate>
      <description>The aim of the study was to validate a newly-designed epicardial coronary artery Doppler probe and test its detection of changes in coronary blood flow velocity. Left anterior descending (LAD) coronary blood flow and flow velocity were evaluated in four pigs with a pericoronary transit time flow (TTF) probe and a newly-designed epicardial Doppler micro-probe. Four consecutive measurements were taken for each of the following conditions: basal, partial stenosis, occlusion, and reperfusion of the LAD. Mean TTF value (mlymin) was 23.2±6.6 in basal condition, 16.2±5.7 after partial LAD stenosis, 0.1±0.3 during LAD occlusion, and 67.4±23.3 at reperfusion (P&lt;0.001). Similar patterns were recorded in terms of Doppler velocity (cmys) with values of 4.0±1.9 in basal condition, 3.5±2.3 after partial LAD stenosis, 0.5±1.4 during LAD occlusion, and 11.1±5.5 at reperfusion (P&lt;0.001). No significant differences in both TTF and Doppler velocity were detected between basal condition and partial LAD stenosis (Psns). Epicardial coronary arterial Doppler represents a valuable tool to detect coronary arterial flow velocity in basal condition. Although changes in flow velocity are easily recorded after coronary occlusion and reperfusion, modifications after partial coronary stenosis are not clearly defined.</description>
    </item> <item>
      <title>Long-term follow-up after repair of Ebstein's anomaly (Article)</title>
      <link>http://repub.eur.nl/res/pub/30210/</link>
      <pubDate>2008-07-01T00:00:00Z</pubDate>
      <description>Objective: We studied the long-term results of vertical plication repair of Ebstein's anomaly according to Carpentier. Methods: Between 1988 and 2007, 28 patients (mean age 28.8 ± 15.7 years, range 4-58 years) underwent vertical plication repair of Ebstein's anomaly. At operation the anomaly was classified according to Carpentier. In three patients (11%) a cavopulmonary shunt was added at the repair on the indication of impaired right ventricular function. Results: There was no operative mortality. Early mortality was 3.6% (one patient). Actuarial survival and actuarial freedom from reoperation at 19 years were 96% (95% CI; 96-97%) and 72% (95% CI; 53-92%), respectively. Six patients required reoperation, with a successful re-repair in three patients. Mean duration of follow-up was 10.7 ± 6.5 years. One year postoperatively, tricuspid incompetence had decreased significantly (p &lt; 0.001), as had New York Heart Association (NYHA) functional class (p &lt; 0.001). In addition, exercise tolerance had increased (70 ± 19% to 92 ± 9% of predicted values, p &lt; 0.05). Both tricuspid function and NYHA functional class remained essentially unchanged at the end of follow-up, indicating durable haemodynamic and functional results. Conclusion: This study demonstrates favourable long-term results following vertical plication repair of Ebstein's anomaly with low mortality, acceptable morbidity and good haemodynamic and functional results. </description>
    </item> <item>
      <title>Usefulness of Cardiac Magnetic Resonance Imaging Combined With Low-Dose Dobutamine Stress to Detect an Abnormal Ventricular Stress Response in Children and Young Adults After Fontan Operation at Young Age (Article)</title>
      <link>http://repub.eur.nl/res/pub/29178/</link>
      <pubDate>2008-06-01T00:00:00Z</pubDate>
      <description>After Fontan operation, patients are limited in increasing cardiac output and in exercise capacity. This has been related to impaired preload or other factors leading to decreased global ventricular performance with stress. To study these factors, the stress responses of functionally univentricular hearts were assessed at rest and during low-dose dobutamine stress using cardiovascular magnetic resonance imaging. Thirty-two patients after Fontan completion at young age were included (27 with total cavopulmonary connection, 5 with atriopulmonary connection; mean age 13.3 years, range 7.5 to 22.2; 23 male patients; median follow-up after Fontan operation 8.1 years, range 5.2 to 17.8). A multiphase short-axis stack of 10 to 12 contiguous slices of the systemic ventricle was obtained at rest and during low-dose dobutamine stress cardiovascular magnetic resonance imaging (maximum 7.5 μg/kg/min). With stress-testing, heart rate, ejection fraction, and cardiac index increased adequately (p &lt;0.001). There was an abnormal decrease in end-diastolic volume and an adequate decrease in end-systolic volume (p &lt;0.001). Stroke volume did not change with stress testing (p = 0.15). At rest, dominant left ventricles had higher ejection fractions than dominant right ventricles (p = 0.01), but this difference disappeared with stress testing. In conclusion, a functionally univentricular heart after Fontan completion at young age has an adequate increase in ejection fraction with β-adrenergic stimulation. However, as a result of impaired preload with stress, cardiac output can be increased only by increasing heart rate. </description>
    </item> <item>
      <title>Autograft or allograft aortic valve replacement in young adult patients with congenital aortic valve disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/29443/</link>
      <pubDate>2008-06-01T00:00:00Z</pubDate>
      <description>Aims: We analysed the outcome of young adults with congenital aortic valve disease who underwent allograft or autograft aortic valve or root replacement in our institution and evaluated whether there is a preference for either valve substitute. Methods and results: Between 1987 and 2007, 169 consecutive patients with congenital aortic valve disease aged 16-55, participating in our ongoing prospective follow-up study, underwent 63 autograft and 106 allograft aortic valve replacements (AVRs). Mean age was 35 years (SD 10.8), 71% were males. Aetiology was 71% bicuspid valve, 14% other congenital, and 15% BV endocarditis. Twenty-two percent underwent previous cardiac surgery; 11% had an ascending aorta aneurysm. Two patients died in hospital. During follow-up six more patients died and 45 patients required valve-related re-operations. Thirteen-year survival was 97% for autograft and 93% for allograft recipients, 13 year freedom from valve-related re-operation was 63% for autograft and 69% for allograft patients. Conclusion: In patients with congenital aortic valve disease, autograft and allograft AVR show comparable satisfactory early and long-term results, with the increasing re-operation risk in the second decade after operation remaining a major concern. </description>
    </item> <item>
      <title>Steepened aortoseptal angle may be a risk factor for discrete subaortic stenosis in adults (Article)</title>
      <link>http://repub.eur.nl/res/pub/29312/</link>
      <pubDate>2008-05-07T00:00:00Z</pubDate>
      <description>Discussion exists whether discrete subaortic stenosis (DSS) is a congenital or acquired cardiac defect. Currently, it is regarded an "acquired" cardiac defect presumably secondary to altered flow patterns due to morphological abnormalities in the left ventricular outflow tract, as have been shown by some studies in the pediatric population. In this report, we demonstrated a steepened aortoseptal angle in adults with DSS without previous cardiac surgery in comparison to controls. Our results strengthen the hypothesis that altered flow patterns due to a steepened aortoseptal angle are a substrate for development of DSS in adults. </description>
    </item> <item>
      <title>Invited Commentary (Article)</title>
      <link>http://repub.eur.nl/res/pub/29187/</link>
      <pubDate>2008-05-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Cardiac tamponade due to a ruptured aneurysm of the sinus of valsalva (Article)</title>
      <link>http://repub.eur.nl/res/pub/29849/</link>
      <pubDate>2008-05-01T00:00:00Z</pubDate>
      <description>Background and Aim: A sinus of Valsalva aneurysm (SVA) is a rare cardiac anomaly. Rupture of a SVA often causes hemodynamic instability due to intracardiac shunting or cardiac tamponade, therefore immediate diagnosis and urgent treatment are required. Methods: We report an 18-year-old female with cardiac tamponade due to rupture of a localized aneurysm of the right coronary sinus of Valsalva. No other congenital or acquired cardiac anomalies were found. Neurological observation precluded urgent surgery with heparinization and extracorporeal circulation. Results: Semi-urgently the SVA was successfully resected. Conclusions: Semi-urgent surgery for a ruptured aneurysm of the Sinus of Valsalva was successful. In selected cases off pump surgery can be contemplated. </description>
    </item> <item>
      <title>Optimum management of elderly patients with calcified aortic stenosis (Article)</title>
      <link>http://repub.eur.nl/res/pub/32390/</link>
      <pubDate>2008-04-01T00:00:00Z</pubDate>
      <description>Increased life-expectancy has led to a growing elderly population frequently presenting with aortic stenosis. This review focuses on the pathogenesis of calcific aortic stenosis, diagnosis and possible ways to halt the progression to severe symptomatic aortic stenosis, methods of assessing symptoms and severity, and modalities and timing of aortic valve replacement. At present the treatment of aortic stenosis for the majority of patients is surgical, and any patient with symptomatic severe aortic stenosis should be considered for aortic valve replacement. This article also discusses the role of emerging techniques of closed heart valve implantation either transfemoral or transapical, and which patients might be candidates for these new approaches to the treatment of aortic stenosis in the elderly population. </description>
    </item> <item>
      <title>Long-term behavioural and emotional problems in four cardiac diagnostic groups of children and adolescents after invasive treatment for congenital heart disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/29342/</link>
      <pubDate>2008-03-28T00:00:00Z</pubDate>
      <description>Aims: To assess the occurrence of a wide range of behavioural and emotional problems long-term after invasive treatment for congenital heart disease (ConHD) in infancy and childhood. Methods: Parents of 125 ConHD children, aged 7-17, completed the Child Behavior Checklist and 85, 11-17-year-old, ConHD children completed the Youth Self-Report. Results: According to parents' reports of problem behaviours a significant proportion of ConHD children scored in the deviant range (16.9%) compared to the reference group (10.2%). The proportion of ConHD boys scoring in the deviant range according to parents (21.4%) was significantly greater than that in the reference sample (10%). Parents reported significantly higher problems scores for the scales Somatic Complaints, Social Problems, Attention Problems, Internalising and Total Problems compared to the reference group. In contrast, reports of patients were comparable to those of reference peers. No differences were found on the self-reports between problem scores for different cardiac diagnostic groups. Discrepancies between self- and parent-reports were found, indicating that more problems were reported by ConHD patients themselves than by their parents. Conclusion: Overall, parents of ConHD patients reported higher levels of behavioural and emotional problems compared to the reference group whereas patients themselves reported no long-term behavioural impairment compared to same-sex reference peers. Assessing behavioural and emotional problems in ConHD patients can be helpful to detect children at risk for developing psychopathology. Especially younger male ConHD patients deserve special attention. </description>
    </item> <item>
      <title>Ischemia of the lung causes extensive long-term pulmonary injury: An experimental study (Article)</title>
      <link>http://repub.eur.nl/res/pub/30316/</link>
      <pubDate>2008-03-26T00:00:00Z</pubDate>
      <description>Background: Lung ischemia-reperfusion injury (LIRI) is suggested to be a major risk factor for development of primary acute graft failure (PAGF) following lung transplantation, although other factors have been found to interplay with LIRI. The question whether LIRI exclusively results in PAGF seems difficult to answer, which is partly due to the lack of a long-term experimental LIRI model, in which PAGF changes can be studied. In addition, the long-term effects of LIRI are unclear and a detailed description of the immunological changes over time after LIRI is missing. Therefore our purpose was to establish a long-term experimental model of LIRI, and to study the impact of LIRI on the development of PAGF, using a broad spectrum of LIRI parameters including leukocyte kinetics.Methods: Male Sprague-Dawley rats (n = 135) were subjected to 120 minutes of left lung warm ischemia or were sham-operated. A third group served as healthy controls. Animals were sacrificed 1, 3, 7, 30 or 90 days after surgery. Blood gas values, lung compliance, surfactant conversion, capillary permeability, and the presence of MMP-2 and MMP-9 in broncho-alveolar-lavage fluid (BALf) were determined. Infiltration of granulocytes, macrophages and lymphocyte subsets (CD45RA+, CD5+CD4+, CD5+CD8+) was measured by flowcytometry in BALf, lung parenchyma, thoracic lymph nodes and spleen. Histological analysis was performed on HE sections.Results: LIRI resulted in hypoxemia, impaired left lung compliance, increased capillary permeability, surfactant conversion, and an increase in MMP-2 and MMP-9. In the BALf, most granulocytes were found on day 1 and CD5+CD4+and CD5+CD8+-cells were elevated on day 3. Increased numbers of macrophages were found on days 1, 3, 7 and 90. Histology on day 1 showed diffuse alveolar damage, resulting in fibroproliferative changes up to 90 days after LIRI.Conclusion: The short-, and long-term changes after LIRI in this model are similar to the changes found in both PAGF and ARDS after clinical lung transplantation. LIRI seems an independent risk factor for the development of PAGF and resulted in progressive deterioration of lung function and architecture, leading to extensive immunopathological and functional abnormalities up to 3 months after reperfusion. </description>
    </item> <item>
      <title>Changes during exercise of ECG intervals related to increased risk for ventricular arrhythmia in repaired tetralogy of Fallot and their relationship to right ventricular size and function (Article)</title>
      <link>http://repub.eur.nl/res/pub/29294/</link>
      <pubDate>2008-03-14T00:00:00Z</pubDate>
      <description>Purpose: Our study aimed to assess pro-arrhythmogenic electrocardiographic changes during maximal physical exercise in patients operated for Tetralogy of Fallot (TOF). Methods: TOF patients prospectively underwent: 1) bicycle ergometry, 2) cardiac MRI, and 3) 24-hour Holter. ECG data was analyzed at rest, at 60% of peak exercise and at peak exercise. R-R duration, QRS-, QT- and JT-duration and dispersions were assessed. Changes of ECG parameters during exercise were calculated and correlated to RV volume, RVEF, RV wall-mass, PR-percentage and VO2max. Exercise ECG data from healthy controls were used as reference. Results: Thirty-one patients (mean age at repair (SD) 0.8 (0.5) years, age at study 16 (5) years) and 25 controls (age 12 (2) years) were included. With exercise mean QTc and JTc dispersions increased in patients (p &lt; 0.001), but not in controls. At peak exercise JTc dispersion was larger in patients (p &lt; 0.01). QTc did not change with exercise in patients (p = 0.14) and decreased in controls (p &lt; 0.05). At all levels of exercise mean QTc, QRS and QRS dispersion were larger in patients (all p &lt; 0.001). Significant associations were found for; 1) a larger increase of JTc dispersion with a higher PR-percentage, a larger RV volume, a larger RV wall-mass, 2) a larger QTc increase with a larger RV volume and worse RVEF. Conclusion: During physical exercise inhomogeneity of repolarisation, known to predispose for re-entry ventricular arrhythmia, increases in repaired TOF. Larger inhomogeneity is found with more severe PR. </description>
    </item> <item>
      <title>Do We Need Separate Risk Stratification Models for Hospital Mortality After Heart Valve Surgery? (Article)</title>
      <link>http://repub.eur.nl/res/pub/28779/</link>
      <pubDate>2008-03-01T00:00:00Z</pubDate>
      <description>Background: The EuroSCORE (European System for Cardiac Operative Risk Evaluation) is often used to benchmark and predict hospital mortality after cardiac surgery. Based mainly upon coronary surgery patients, EuroSCORE may not be optimal for valve surgery patients. We evaluated the New York (NY) State dedicated valve surgery models and compared their performance to the EuroSCORE model. Methods: Required model variables were collected prospectively for all patients, followed by calculation of predictive mortality rates using the logistic and additive EuroSCORE, the logistic and additive NY State models for valve surgery without concomitant coronary surgery (isolated valve surgery) and the logistic and additive NY State models for combined valve and coronary surgery. Results: Observed mortality was 2.8% (25 of 904) for isolated valve surgery and 6.8% (27 of 395) for valve plus coronary surgery. Logistic NY State and EuroSCORE expected mortality for isolated valve surgery was respectively 3.0% and 6.1%, and for valve plus coronary surgery 5.9% and 7.8%. The logistic NY State model for isolated valve surgery showed better discrimination (c-index 0.86 versus 0.76) and calibration than the logistic EuroSCORE. Discriminatory power for the logistic NY State model for valve plus coronary surgery was comparable to the logistic EuroSCORE (c-index 0.74 versus 0.72), as was calibration. Conclusions: Our results suggest that dedicated risk models for valve surgery may be useful to provide more valid estimates of hospital mortality after heart valve surgery. Further exploration is needed to demonstrate general applicability of our results and assess the possible additional value of separate models for isolated valve surgery and valve plus coronary artery surgery, or aortic and mitral valve surgery, or both. </description>
    </item> <item>
      <title>A historical comparison of long-term behavioral and emotional outcomes in children and adolescents after invasive treatment for congenital heart disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/28873/</link>
      <pubDate>2008-03-01T00:00:00Z</pubDate>
      <description>Background/Purpose: Children with congenital heart disease (ConHD) are known to be vulnerable to behavioral and emotional problems. In this study, a historical comparison is made between the level of behavioral and emotional problems in a sample of children and adolescents with ConHD treated recently vs a comparable historical sample operated upon before 1980 in the same institute. The hypothesis was that improvements in medical care would result in more favorable behavioral and emotional outcomes for children and adolescents with ConHD treated recently, that is, between 1990 and 1995, compared with same-aged patients operated on before 1980. Methods: To assess behavioral and emotional problems, the Child Behavior Checklist (parent report) and Youth Self-Report were used. The historical samples (n = 98 and n = 123, respectively) and recent samples (n = 90 and n = 84, respectively) consisted of 4 diagnostic groups. Results: Parents and patients from the recent sample with ConHD reported fairly similar levels of behavioral and emotional problems compared with parents and patients in the historical sample with ConHD. Conclusion: Despite evident improvements in diagnostic and surgical techniques and medical treatment of ConHD over the past decades, virtually no changes were found in levels of problem behavior of the recent patient sample compared with the historical patient sample, who both underwent invasive treatment for ConHD. </description>
    </item> <item>
      <title>Early Detection of Left Ventricular Dysfunction by Doppler Tissue Imaging and N-terminal Pro-B-type Natriuretic Peptide in Patients with Symptomatic Severe Aortic Stenosis (Article)</title>
      <link>http://repub.eur.nl/res/pub/29860/</link>
      <pubDate>2008-03-01T00:00:00Z</pubDate>
      <description>Background: Patients with severe aortic stenosis (AS) require valve replacement before development of irreversible left ventricular (LV) dysfunction. It has been postulated that Doppler tissue imaging (DTI) parameters are more sensitive to detect subtle LV dysfunction compared with conventional echocardiographic parameters. Objective: We sought to assess early LV dysfunction with DTI-derived echocardiographic parameters and N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with severe AS and normal LV ejection fraction. Methods: A total of 29 patients (mean age 65 ± 12 years, 15 male) with symptomatic severe AS and 17 control subjects were included in the study. DTI was performed at the level of the mitral lateral (mlat) and septal (msep) annulus. Systolic (Sm), early (Em), and late (Am) diastolic velocities were measured, and E/Em ratio was calculated. NT-proBNP was determined by an electrochemiluminescence immunoassay. Results: Baseline characteristics between patients and control subjects were similar regarding LV ejection fraction and mitral inflow E/A ratio. However, patients with AS had significantly lower DTI values (Sm, Em, Am) compared with control subjects. Moreover, LV filling pressures, expressed by the E/Em ratio, were significantly higher in patients. Correlation analysis showed a relationship between the natural logarithm of NT-proBNP and aortic valve area, Smlat, and E/Emsepratio. Using stepwise multiple linear regression, Smlatwas found to be independently related to NT-proBNP. Conclusions: In patients with severe AS and normal LV ejection fraction, DTI showed LV systolic and diastolic dysfunction compared with control subjects. DTI-derived variables, and especially Smlat, were correlated with NT-proBNP levels. </description>
    </item> <item>
      <title>Consequences of a selective approach toward pulmonary valve replacement in adult patients with tetralogy of Fallot and pulmonary regurgitation (Article)</title>
      <link>http://repub.eur.nl/res/pub/28935/</link>
      <pubDate>2008-01-01T00:00:00Z</pubDate>
      <description>Objective: The aim of the study was to assess the long-term results of a selective policy toward pulmonary valve replacement in adult patients with repaired tetralogy of Fallot and severe pulmonary regurgitation. Methods: Sixty-seven patients with tetralogy of Fallot were followed up from 15 ± 3 years until 27 ± 3 years after surgery. Results: Twenty-two patients had mild-to-moderate pulmonary regurgitation. No significant changes occurred in the follow-up period. Of 45 patients with severe pulmonary regurgitation and severe right ventricular dilatation, 28 (62%) remained free of symptoms and did not undergo pulmonary valve replacement. No changes in right ventricular size or exercise capacity were found. In 3 (11%) of 28 patients, QRS duration increased to more than 180 ms. Seventeen patients had symptoms and underwent pulmonary valve replacement: 9 (54%) of 17 patients improved clinically and echocardiographically, and QRS duration shortened postoperatively. Right ventricular dimensions did not regress despite pulmonary valve replacement in 8 patients. Conclusion: Refraining from pulmonary valve replacement in asymptomatic patients led to no measurable deterioration in 25 (89%) of 28 patients. Referring symptomatic patients for pulmonary valve replacement led to an improvement in 9 (53%) of 17 patients. In 11 (24%) of 45, a selective approach led to questionable or unsatisfactory results. </description>
    </item> <item>
      <title>Inclusion of the transcervical approach in the video-assisted thoracoscopic extended thymectomy (BATET) for myasthenia gravis: A prospective trial [7] (Article)</title>
      <link>http://repub.eur.nl/res/pub/29895/</link>
      <pubDate>2008-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Connecting the Centrimag Levitronix Pump to Berlin Heart Excor Cannulae; A New Approach to Bridge to Bridge (Article)</title>
      <link>http://repub.eur.nl/res/pub/30163/</link>
      <pubDate>2008-01-01T00:00:00Z</pubDate>
      <description>Background: An increasing number of children are requiring circulatory suport. Hospitals offering pediatric Ventricular Assist Device (VAD) should have devices of different sizes available to cover the full range of patient sizes incurring considerable expense. As in adults, post-operative bleeding often complicates VAD implantation. The use of a Levitronix Centrimag centrifugal pump, connected to Berlin Heart Excor cannulae, seems an attractive and logic combination, both in terms of patient safety and of hospital economics. Methods: We describe 3 children with therapy resistant cardiac failure who underwent extracorporeal membrane oxygenation (ECMO) as a rescue before proceeding to placement of the Berlin Heart Excor paracorporeal assist device. The Levitronix Centrimag pump was used as an intermediate device to allow the patients to be stabilised. Therefore, only Berlin Heart cannulae of different sizes have to be readily available; if successful stabilization can be achieved, the Berlin Heart Excor ventricles and the drive unit can then be ordered to replace the Levitronix pump. Results: Two patients were successfully stabilised with the Levitronix pump and were switched to the definitive Berlin Heart Excor ventricles after 6 days of support. The third child succumbed due to intractable pulmonary hemorrhage in severely damaged lungs. No device related complications, especially no thrombo-embolic events, occurred during Levitronix support. Conclusion: The Levitronix Centrimag pump was easy to handle and gave effective circulatory support, the patients were only switched to the Berlin Heart Excor system after stabilization. In patients with a high risk of failure, it is a relatively cheap but safe and effective support system. </description>
    </item> <item>
      <title>Low molecular starch versus gelatin plasma expander during CPB: Does it make a difference? (Article)</title>
      <link>http://repub.eur.nl/res/pub/35886/</link>
      <pubDate>2007-12-01T00:00:00Z</pubDate>
      <description>Background: Non-protein plasma expanders carry a risk of potentially severe allergic reactions. As prime for cardiopulmonary bypass, we routinely use a gelatin plasma expander. Plasma expanding during anesthesia is achieved with high molecular starch (200/0.5 kDalton) in combination with Ringer Lactate solution (RL) and in the Intensive Care Unit (ICU) with a low molecular starch (130/0.4 kDalton). We evaluated the feasibility of low molecular starch in combination with RL (group LMSRL) versus gelatin plasma expanding (group GPE) for priming CPB circuits in patients undergoing cardiac surgery in a randomized prospective trial. Methods: One hundred and eighty adults who underwent primary valve or coronary artery bypass graft (CABG) surgery were equally stratified into 3 series of 60 patients with the routinely used oxygenators; Capiox RX-25, CML Duo and Quadrox-D. Then they were randomised by drawing lots and allocated into the LMSRL or GPE groups. We compared hematocrit, hemoglobin, platelet count, activated clotting time (ACT), lactate and colloid osmotic pressure (COP), blood loss, transfusion need, urine production and ICU stay. In addition, we monitored the average trans-oxygenator fluid resistance (AFR) for each type of oxygenator. Results: The COP is significantly lower in the LMSRL group (20 mmHg ± 0.2 versus 18 mmHg ± 0.2, p &lt; 0.0001); as was the total use of plasma expanders (3846 ml ± 98 versus 3059 ml ± 77, p &lt;0.001). All other parameters were not significantly different. When comparing the observed AFR for the three types of oxygenators, a lower AFR in the LMSRL group (p &lt; 0.02) was noted for the Capiox RX-25®. Conclusions: This study shows a lower need for plasma expanders in patients who receive only starch plasma expanders. Further, we noted a lower COP in the LMSRL group, but since the mean COP was &gt; 17 ± 0.2 mmHg, this cannot be considered of clinical importance. In conclusion, our study result supports the use of low molecular starch as a good alternative choice for priming CPB. </description>
    </item> <item>
      <title>Is OpenSDE an alternative for dedicated medical research databases? An example in coronary surgery (Article)</title>
      <link>http://repub.eur.nl/res/pub/36847/</link>
      <pubDate>2007-12-01T00:00:00Z</pubDate>
      <description>Background. When using a conventional relational database approach to collect and query data in the context of specific clinical studies, a study with a new data set usually requires the design of a new database and entry forms. OpenSDE (SDE = Structured Data Entry) is intended to provide a flexible and intuitive way to create databases and entry forms for the collection of data in a structured format. This study illustrates the use of OpenSDE as a potential alternative to a conventional approach with respect to data modelling, database creation, data entry, and data extraction. Methods. A database and entry forms are created using OpenSDE and MSAccess to support collection of coronary surgery data, based on the Adult Cardiac Surgery Data Set of the Society of Thoracic Surgeons. Data of 52 cases are entered and nine different queries are designed, and executed on both databases. Results. Design of the data model and the creation of entry forms were experienced as more intuitive and less labor intensive with OpenSDE. Both resulting databases provided sufficient expressiveness to accommodate the data set. Data entry was more flexible with OpenSDE. Queries produced equal and correct results with comparable effort. Conclusion. For prospective studies involving well-defined and straight forward data sets, OpenSDE deserves to be considered as an alternative to the conventional approach. </description>
    </item> <item>
      <title>Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier-Edwards supra-annular valve (Article)</title>
      <link>http://repub.eur.nl/res/pub/35244/</link>
      <pubDate>2007-09-01T00:00:00Z</pubDate>
      <description>Objective: Numerous reports have been published documenting the results of aortic valve replacement. It is often not easy to translate these outcomes involving the condition of the valve into the actual consequences for the patient. We previously developed an alternative method to study outcome after aortic valve replacement that allows direct estimation of patient outcome after aortic valve replacement: microsimulation modeling. The goal of this article is to provide insight into microsimulation methodology and to give an overview of the advantages and disadvantages of simulation methods (in particular microsimulation) in comparison with standard methods of outcome analysis. Methods: By using a primary dataset containing 1847 patients and 14,429 patient-years, advantages and disadvantages of standard methods of outcome analysis are discussed, and the potential role of microsimulation is illustrated by means of a step-by-step explanation of building, testing, and using such a model. Results: Total life expectancy, event-free life expectancy, and reoperation-free life expectancy for a 65-year-old male patient were 10.6 years, 9.2 years, and 9.8 years, respectively. Lifetime risk of reoperation due to structural valve deterioration was 13.3%. Conclusions: Microsimulation is capable of providing accurate estimates of age-related life expectancy and lifetime risk of reoperation for patients who underwent aortic valve replacement with the Carpentier-Edwards supra-annular valve. It provides a useful tool to facilitate and optimize the choice for a specific heart valve prosthesis in a particular patient. </description>
    </item> <item>
      <title>Can late supraclavicular echo Doppler reliably predict angiographical string sign of lima to lad area grafts (Article)</title>
      <link>http://repub.eur.nl/res/pub/36192/</link>
      <pubDate>2007-08-01T00:00:00Z</pubDate>
      <description>Objective: To investigate whether supraclavicular ultrasonography of left internal mammary artery (LIMA) to left anterior descending (LAD) area grafts can reliably predict (distal) string sign grafts on arteriography. Methods: Fifty-five patients (42 M, 61 ± 7 years) with the LIMA to LAD area grafting were prospectively studied. Control arteriography was performed at 1.4 ± 0.8 years postoperatively. Angiography demonstrated in 46 patients (group I) functional grafts, in 4 patients (group II) sequential distal string sign grafts and in 5 patients (group III) total string sign grafts. Ultrasonography was performed at 1.8 ± 0.8 year postoperatively and compared with control angiography. Data were tested by unpaired t- and ANOVA tests. The diagnostic accuracy was assessed by the area under the curve of the Receiver Operator Characteristic. A formula was developed to predict the probability of (distal) string sign phenomena of sequential as well as single LIMA grafts. Results: Between the groups all duplex parameters showed a highly significant linear relation (p ≤ 0.004) and all parameters between group I and III are significantly different with high Area Under Curve values. The model for the probability of (distal) string sign grafts fitted best with diastolic and systolic peak velocities as the most discriminative factors for (distal) string sign grafts. Conclusions: Postoperative supraclavicular duplex as a method to assess the patency of LIMA to LAD area grafts allows discriminating functional grafts from (distal) string sign grafts. </description>
    </item> <item>
      <title>The Ross operation: A Trojan horse? (Article)</title>
      <link>http://repub.eur.nl/res/pub/35749/</link>
      <pubDate>2007-08-01T00:00:00Z</pubDate>
      <description>Aims: The Ross operation is the operation of choice for children who require aortic valve replacement (AVR) and may also provide a good option in selected adult patients. Although the autograft does not require anticoagulation and has a superior haemodynamic profile, concern regarding autograft and allograft longevity has risen. In this light, we report the 13-year results of our prospective autograft cohort study. Methods and results: Between 1988 and 2005, 146 consecutive patients underwent AVR with a pulmonary autograft at Erasmus Medical Center Rotterdam. Mean age was 22 years (SD 13; range 4 months-52 years), 66% were male. Hospital mortality was 2.7% (N = 4); during follow-up four more patients died. Thirteen-year survival was 94 ± 2%. Over time, 22 patients required autograft reoperation for progressive neo-aortic root dilatation. In addition, eight patients required allograft reoperation. Freedom from autograft reoperation at 13 years was 69 ± 7%. Freedom from allograft reoperation for structural failure at 13 years was 87 ± 5%. Risk factors for autograft reoperation were previous AVR and adult patient age. Conclusion: Although survival of the Rotterdam autograft cohort is excellent, over time a worrisome increase in reoperation rate is observed. Given the progressive autograft dilatation, careful follow-up of these patients is warranted in the second decade after operation. </description>
    </item> <item>
      <title>Long-term follow-up and quality of life after closure of ventricular septal defect in adults (Article)</title>
      <link>http://repub.eur.nl/res/pub/36606/</link>
      <pubDate>2007-08-01T00:00:00Z</pubDate>
      <description>Objective: To study patients who underwent surgical closure of a congenital ventricular septal defect (VSD) and presenting at adult age. Methods and results: A retrospective study was carried out of 28 patients (15 male) operated upon between 1980 and 2004. Patients were investigated by echocardiography, ECG and assessed for quality of life by a questionnaire. The indication for surgery was volume overload in 11 patients, endocarditis in 8, aortic valve regurgitation in 8 and the combination of a VSD with subvalvular aortic stenosis in 1. Follow-up was complete with a mean duration of follow-up of 13 years. There was no early or late mortality. One patient was reoperated for recurrent VSD. Twenty-five patients underwent echocardiography, which revealed a trivial residual VSD in two and mild aortic regurgitation in 10 (40%) patients. One patient was in atrial fibrillation. Health related quality of life in the dimensions cognitive functioning and sleep differed significantly from that of the general population. Conclusion: With a relative difference in indications for closure of a VSD in adulthood, surgical closure of VSD at adult age is an adequate and safe procedure, with good results on long-term follow-up. Progression of aortic valve regurgitation is a matter of concern. </description>
    </item> <item>
      <title>Intraoperative evaluation of micromultiplane transesophageal echocardiographic probe in surgery for congenital heart disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/36993/</link>
      <pubDate>2007-08-01T00:00:00Z</pubDate>
      <description>Introduction: In the last years, transesophageal transducers for multiplane Doppler echocardiography have demonstrated their superior imaging performance in pediatric patients undergoing cardiac surgery. To date, the size of these probes has limited their use in neonates and small children. New technologies allowing performing TEE in smaller patients are therefore promising. Methods: We report our clinical experience with the Oldelft micromultiplane TEE probe (8.2-7 mm diameter tip with a 5.2 mm diameter shaft) specifically meant for use in neonates. Results: Forty-two patients were examined intra-operatively using the micromulti TEE harmonic transducer. Patients examined ranged in age from 4 days to 6 years and ranged in weight from 2.5 to 23.8 kg. In two patients we had to adapt ventilatory settings because of increased airway resistance after probe insertion. In 3 patients surgical re-intervention was performed due to TEE assessment immediately after weaning from bypass. In two patients significant obstruction of the right ventricular outflow tract was still present after Fallot correction, and one patient had an additional muscular ventricular septal defect still present after VSD closure. Conclusions: The micromulti TEE harmonic transducer provided excellent diagnostic intra-operative TEE in neonates and small children without major complications, special attention should be taken for ventilatory parameters in neonates less than 3 kg. </description>
    </item> <item>
      <title>The role of collagen cross-links in biomechanical behavior of human aortic heart valve leaflets - Relevance for tissue engineering (Article)</title>
      <link>http://repub.eur.nl/res/pub/36624/</link>
      <pubDate>2007-07-01T00:00:00Z</pubDate>
      <description>A major challenge in tissue engineering of functional heart valves is to determine and mimic the dominant tissue structures that regulate heart valve function and in vivo survival. In native heart valves, the anisotropic matrix architecture assures sustained and adequate functioning under high-pressure conditions. Collagen, being the main load-bearing matrix component, contributes significantly to the biomechanical strength of the tissue. This study investigates the relationship between collagen content, collagen cross-links, and biomechanical behavior in human aortic heart valve leaflets and in tissue-engineered constructs. In the main loading direction (circumferential) of native valve leaflets, a significant positive linear correlation between modulus of elasticity and collagen cross-link concentration was found, whereas no correlation between modulus of elasticity and collagen content was found. Similar findings were observed in tissue-engineered constructs, where cross-link concentration was higher for dynamically strained constructs then for statically cultured controls. These findings suggest a dominant role for collagen cross-links over collagen content with respect to biomechanical tissue behavior in human heart valve leaflets. They further suggest that dynamic tissue straining in tissue engineering protocols can enhance cross-link concentration and biomechanical function. </description>
    </item> <item>
      <title>Effects of cardiopulmonary bypass circuit reduction and residual volume salvage on allogeneic transfusion requirements in infants undergoing cardiac surgery (Article)</title>
      <link>http://repub.eur.nl/res/pub/37016/</link>
      <pubDate>2007-06-01T00:00:00Z</pubDate>
      <description>Cardiopulmonary bypass in children may cause severe hemodilution and can lead to excessive perioperative blood loss and high transfusion requirements. Minimization of cardiopulmonary bypass circuit and salvage of red blood cells from the residual volume after the procedure are widely utilized to reduce allogeneic transfusion. We evaluated the effectiveness of those measures introduced in infant cardiac surgery in our institution. This retrospective observational study included 148 consecutive infants between 1 and 12 months of age, with a body weight &lt;10 kg, who underwent an elective cardiac operation between 1997 and 2005. Patients were divided into three groups defined by the circuit prime volume; 700 ml (Group 1), 450 ml (Group 2) and 330 ml (Group 3). In Group 1 residual volume after perfusion was discarded and in Groups 2 and 3 was processed in a cell saving device. Analyzed variables were: perioperative blood loss, transfusion of homologous blood products and cell salvage product, and hematology data. Reduction of the circuit volume significantly diminished use of red blood cell concentrates from 1.6 units to 0.8 units (P&lt;0.0001), and fresh frozen plasma from 1.3 units to 0.4 units (P&lt;0.0001). Utilization of the cell salvage product reduced significantly (P=0.023) the postoperative need for homologous blood transfusion. Therefore, both measures proved to be effective in reducing homologous blood transfusion in infant cardiac surgery.</description>
    </item> <item>
      <title>Three-dimensional transesophageal echocardiography in Ebstein's anomaly (Article)</title>
      <link>http://repub.eur.nl/res/pub/20745/</link>
      <pubDate>2007-05-01T00:00:00Z</pubDate>
      <description>Three-dimensional (3D) transthoracic echocardiography has advantages over traditional two-dimensional (2D) echocardiography in visualizing tricuspid valve morphology in Ebstein's anomaly. We describe the application of intra-operative 3D transesophageal echocardiography during a tricuspid valve repair procedure in a patient with Ebstein's anomaly. Intra-operatively three-dimensional transesophageal echocardiography (3D TEE) data sets revealed morphology and function of the tricuspid valve, right ventricle outflow tract (RVOT) and pulmonary valve before and after repair. Tricuspid valve leaflet morphology and coaptation as visualized with 3D TEE proved to be consistent with intra-operative findings. Analysis of the tricuspid valve, RVOT and pulmonary valve in the multi-planar review (MPR) mode revealed a bicuspid pulmonary valve, which had not been noticed on the preoperative 2D echocardiographic work-up. In this patient with Ebstein's anomaly, 3D TEE provided additional information on morphology and function of tricuspid valve, RVOT and pulmonary valve.</description>
    </item> <item>
      <title>Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study (Article)</title>
      <link>http://repub.eur.nl/res/pub/36657/</link>
      <pubDate>2007-05-01T00:00:00Z</pubDate>
      <description>Objective: Whether allografts are the biological valve of choice for AVR in non-elderly patients remains a topic of debate. In this light we analyzed our ongoing prospective allograft AVR cohort and compared allograft durability with other biological aortic valve substitutes. Methods: Between April 1987 and October 2005, 336 patients underwent 346 allograft AVRs (95 subcoronary, 251 root replacement). Patient and perioperative characteristics, cumulative survival, freedom from reoperation, and valve-related events were analyzed. Using microsimulation, for adult patients, age-matched actual freedom from allograft reoperation was compared to porcine and pericardial bioprostheses. Results: Mean age was 45 years (range 1 month to 83 years); 72% were males. Etiology was mainly endocarditis 32% (active 22%), congenital 31%, degenerative 9%, and aneurysm/dissection 12%. Twenty-seven percent underwent prior cardiac surgery. Hospital mortality was 5.5% (N = 19). During follow-up (mean 7.4 years, maximum 18.5 years, 98% complete), 54 patients died; there were 57 valve-related reoperations (3 early technical, 11 non-structural, 39 structural valve deterioration (SVD), 4 endocarditis), 5 cerebrovascular accidents, 1 fatal bleeding, 8 endocarditis. Twelve-year cumulative survival was 71% (SE 3), freedom from reoperation for SVD 77% (SE 4); younger patient age was associated with increased SVD rates. Actual risk of allograft reoperation was comparable to porcine and pericardial bioprostheses in a simulated age-matched population. Conclusions: The use of allografts for AVR is associated with low occurrence rates of most valve-related events, but over time the risk of SVD increases, comparable to stented xenografts. It remains in our institute the preferred valve substitute only for patients with active aortic root endocarditis and for patients in whom anticoagulation should be avoided. </description>
    </item> <item>
      <title>Acute dehiscence of a valve prosthesis 5 years after implantation (Article)</title>
      <link>http://repub.eur.nl/res/pub/35811/</link>
      <pubDate>2007-04-25T00:00:00Z</pubDate>
      <description>Propionibacterium acnes, a common human skin organism [Perry A.L., Lambert P.A., Under the microscope Propionibacterium acnes, Lett App Microbiol 2006; 42:185-186], mostly considered a contaminant, has rarely been associated with cases of infectious endocarditis [Vanagt W.Y., Daenen W.J., Delhaas T., Propionibacterium acnes endocarditis on an annuloplasty ring in an adolescent boy, Heart 2004; 90:56]. We report on a 48-year old man with a history of mitral valve replacement who acutely developed dyspnoea, tachypnoea and forward failure. Transesophageal echocardiography showed a dehiscence of the St. Jude mechanical mitral prosthesis necessitating urgent surgery. The prosthesis was replaced by another St. Jude mechanical valve. Blood cultures were initially negative but after a prolonged incubation period the tissue cultures became positive for Propionibacterium acnes. In cases of valvular dehiscence without macroscopic signs of endocarditis, communication between clinicians and the laboratory is important in order to incubate blood and tissue samples for a longer period of time to be able to detect exceptional causes of endocarditis. </description>
    </item> <item>
      <title>Diastolic function in repaired tetralogy of fallot at rest and during stress: Assessment with MR imaging (Article)</title>
      <link>http://repub.eur.nl/res/pub/35497/</link>
      <pubDate>2007-04-01T00:00:00Z</pubDate>
      <description>Purpose: To prospectively assess, with magnetic resonance (MR) imaging, right ventricular (RV) diastolic function after repair of tetralogy Fallot (TOF) at rest and during pharmacologic stress and to study relationship between main pulmonary artery end-diastolic forward flow (EDFF) (indicative of restrictive RV physiology) and clinical status. Materials and Methods: Institutional medical ethics committee approval and patient or parent informed consent were obtained. Patients with TOF corrected through the transatrial-transpulmonary approach underwent MR imaging at rest and during dobutamine stress and maximal exercise testing. Two-dimensional (2D) cine volumetric data were acquired. Flow measurements were performed with a standard 2D flow-sensitized sequence. MR imaging flow curves for tri-cuspid and pulmonary valves were combined into RV time-volume change curves, from which indexes of RV filling were derived. Patient results were compared with published data in control subjects. Student t tests, Mann-Whitney U tests, analysis of covariance, and paired and one-sample t tests were used. Results: Thirty-six patients (mean age at repair, 0.9 year ± 0.5 [standard deviation]; median age at study inclusion, 17 years, [range, 7-23 years]; 26 male and 10 female patients) were included. Abnormalities in RV filling included impaired relaxation (prolonged deceleration time, P = .002; smaller early filling fraction, P = .02) in the entire group compared with published data in healthy control subjects and signs of restriction to RV filling (smaller atrial filling fraction and higher early filling/atrial filling peak ratio, P &lt; .05 for both) in patients with EDFF (n = 24) compared with patients without EDFF (n = 12). Stress response was abnormal in patients with EDFF, who developed impaired RV relaxation not appreciated at rest. Patients with EDFF had more severe pulmonary regurgitation (P &lt; .05) and poorer exercise performance (P &lt; .001). Conclusion: In patients with TOF corrected with currently widely accepted surgical strategies, pulmonary artery EDFF relates to worse clinical state at mid- to long-term follow-up. Dobutamine stress imaging may unmask abnormalities in RV diastolic filling not appreciated with rest imaging alone. </description>
    </item> <item>
      <title>Virtual reality 3D echocardiography in the assessment of tricuspid valve function after surgical closure of ventricular septal defect (Article)</title>
      <link>http://repub.eur.nl/res/pub/36926/</link>
      <pubDate>2007-03-12T00:00:00Z</pubDate>
      <description>Background. This study was done to investigate the potential additional role of virtual reality, using three-dimensional (3D) echocardiographic holograms, in the postoperative assessment of tricuspid valve function after surgical closure of ventricular septal defect (VSD). Methods. 12 data sets from intraoperative epicardial echocardiographic studies in 5 operations (patient age at operation 3 weeks to 4 years and bodyweight at operation 3.8 to 17.2 kg) after surgical closure of VSD were included in the study. The data sets were analysed as two-dimensional (2D) images on the screen of the ultrasound system as well as holograms in an I-space virtual reality (VR) system. The 2D images were assessed for tricuspid valve function. In the I-Space, a 6 degrees-of-freedom controller was used to create the necessary projectory positions and cutting planes in the hologram. The holograms were used for additional assessment of tricuspid valve leaflet mobility. Results. All data sets could be used for 2D as well as holographic analysis. In all data sets the area of interest could be identified. The 2D analysis showed no tricuspid valve stenosis or regurgitation. Leaflet mobility was considered normal. In the virtual reality of the I-Space, all data sets allowed to assess the tricuspid leaflet level in a single holographic representation. In 3 holograms the septal leaflet showed restricted mobility that was not appreciated in the 2D echocardiogram. In 4 data sets the posterior leaflet and the tricuspid papillary apparatus were not completely included. Conclusion. This report shows that dynamic holographic imaging of intraoperative postoperative echocardiographic data regarding tricuspid valve function after VSD closure is feasible. Holographic analysis allows for additional tricuspid valve leaflet mobility analysis. The large size of the probe, in relation to small size of the patient, may preclude a complete data set. At the moment the requirement of an I-Space VR system limits the applicability in virtual reality 3D echocardiography in clinical practice. </description>
    </item> <item>
      <title>Dissection of a dilated autograft root (Article)</title>
      <link>http://repub.eur.nl/res/pub/35564/</link>
      <pubDate>2007-03-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Clinical condition at mid-to-late follow-up after transatrial-transpulmonary repair of tetralogy of Fallot (Article)</title>
      <link>http://repub.eur.nl/res/pub/35612/</link>
      <pubDate>2007-02-01T00:00:00Z</pubDate>
      <description>Objectives: To assess the clinical condition at mid-to-late follow-up in tetralogy of Fallot corrected by a transatrial-transpulmonary approach at a young age and to identify risk factors associated with right ventricular dilation/dysfunction and with decreased exercise tolerance. Methods: Patients with tetralogy of Fallot underwent cardiac magnetic resonance imaging, maximal bicycle ergometry, electrocardiography, Holter monitoring, and spirometry. Multivariate linear regression analyses were used to determine independent predictors for selected clinical parameters. Results: Fifty-nine patients (mean ± SD), age at repair 0.9 ± 0.5 years, interval since repair 14 ± 5 years, were included. The median pulmonary regurgitant fraction was 32% (0%-57%). Compared with published data on healthy controls, Fallot patients had significantly larger right ventricular end-diastolic and end-systolic volumes and smaller right ventricular and left ventricular ejection fractions. Maximum oxygen consumption was 97% ± 17% and maximum workload 89% ± 13% of predicted. Median QRS duration was 110 ms (82-161 ms). No important ventricular arrhythmias were found. Compared with patients without a transannular patch, patients with a patch had more pulmonary regurgitation, a larger right ventricle, worse right ventricular and left ventricular ejection fractions, but comparable exercise capacity. Multivariate regression analysis identified the following independent determinants for larger right ventricular volumes: longer interval since repair, longer QRS duration, and higher pulmonary regurgitation percentage. The following were independent determinants for smaller right ventricular ejection fraction: abnormal right ventricular outflow tract wall motion, longer interval since repair, and longer QRS duration. For smaller maximum oxygen consumption, the independent determinants were smaller right ventricular ejection fraction and longer QRS duration. Conclusions: At mid-to-late follow-up, clinical condition in tetralogy of Fallot corrected according to contemporary surgical approaches appears well preserved. However, even these patients show right ventricular dilation and dysfunction associated with impaired functional capacity. Abnormalities relate to right ventricular outflow tract motion abnormalities, longer interval since repair, longer QRS duration, and more severe pulmonary regurgitation. </description>
    </item> <item>
      <title>Preserved hyperaemic response in (distal) string sign left internal mammary artery grafts (Article)</title>
      <link>http://repub.eur.nl/res/pub/36702/</link>
      <pubDate>2007-02-01T00:00:00Z</pubDate>
      <description>Objective: To correlate supraclavicular ultrasonography at rest and in hyperaemic response with angiographically patent and (distal) 'string sign' left internal mammary artery (LIMA) to left anterior descending (LAD) area grafts. Methods: Fifty-three patients with LIMA to LAD area grafting were prospectively entered in a follow-up study. Arteriography (native and LIMA) was performed at 1.4 ± 0.8 years postoperatively and ultrasonography was performed at rest, in hyperaemic response and 2 min after hyperaemic response at 1.8 ± 0.8 years postoperatively and was compared to arteriography. Ultrasonographic parameters analysed were systolic and diastolic peak velocity, systolic and diastolic velocity integral, diastolic/systolic peak velocity ratio and diastolic/total velocity integral ratio. Results: One patient was excluded because obesity hampered ultrasonography. Arteriography demonstrated functional grafts in 43 patients (group I), sequential distal 'string sign grafts' in 4 patients (group II) and total 'string sign grafts' in 5 patients (group III). Between the groups all ultrasonographic velocities showed a significant linear relation (p ≤ 0.013) at rest and during maximal hyperaemic response all velocities increased significantly within all groups (p ≤ 0.018). A significant decrease was found 2 min after hyperaemic response and diastolic velocities showed a significant linear relation (p ≤ 0.032). Conclusions: String sign LIMA grafts' were found in 9/52 (17.3%) patients. All patent and all 'string sign grafts' showed a shift towards a coronary flow profile in the proximal segment postoperatively. The study revealed the 'functionality' of the patent and the (distal) 'string sign LIMA graft' in regard to myocardial oxygen demand. 'String sign grafts' are 'recruitable' on demand. </description>
    </item> <item>
      <title>Anaesthesiological and ventilatory precautions during cardiac surgery in Steinert's disease: A case report (Article)</title>
      <link>http://repub.eur.nl/res/pub/36337/</link>
      <pubDate>2007-01-01T00:00:00Z</pubDate>
      <description>Myotonic dystrophia type I or Steinert's disease is a progressive multisystemic-inherited neuromuscular disease. Higher sensitivity to sedatives, anaesthetic, and neuromuscular blocking agents may result in cardiovascular and respiratory complications. We describe the anaesthesiological and ventilatory measures in a 43-year-old patient with Steinert's disease successfully undergoing cardiac surgery. </description>
    </item> <item>
      <title>The effect of open lung ventilation on right ventricular and left ventricular function in lung-lavaged pigs (Article)</title>
      <link>http://repub.eur.nl/res/pub/8282/</link>
      <pubDate>2006-01-01T00:00:00Z</pubDate>
      <description>INTRODUCTION: Ventilation according to the open lung concept (OLC)
      consists of recruitment maneuvers, followed by low tidal volume and high
      positive end-expiratory pressure, aiming at minimizing atelectasis. The
      minimization of atelectasis reduces the right ventricular (RV) afterload,
      but the increased intrathoracic pressures used by OLC ventilation could
      increase the RV afterload. We hypothesize that when atelectasis is
      minimized by OLC ventilation, cardiac function is not affected despite the
      higher mean airway pressure. METHODS: After repeated lung lavage, each pig
      (n = 10) was conventionally ventilated and was ventilated according to OLC
      in a randomized cross-over setting. Conventional mechanical ventilation
      (CMV) consisted of volume-controlled ventilation with 5 cmH2O positive
      end-expiratory pressure and a tidal volume of 8-10 ml/kg. No recruitment
      maneuvers were performed. During OLC ventilation, recruitment maneuvers
      were applied until PaO2/FiO2 &gt; 60 kPa. The peak inspiratory pressure was
      set to obtain a tidal volume of 6-8 ml/kg. The cardiac output (CO), the RV
      preload, the contractility and the afterload were measured with a
      volumetric pulmonary artery catheter. A high-resolution computed
      tomography scan measured the whole lung density and left ventricular (LV)
      volumes. RESULTS: The RV end-systolic pressure-volume relationship,
      representing RV afterload, during steady-state OLC ventilation (2.7 +/-
      1.2 mmHg/ml) was not significantly different compared with CMV (3.6 +/-
      2.5 mmHg/ml). Pulmonary vascular resistance (OLC, 137 +/- 49 dynes/s/cm5
      versus CMV, 130 +/- 34 dynes/s/cm5) was comparable between groups. OLC led
      to a significantly lower amount of atelectasis (13 +/- 2% of the lung
      area) compared with CMV (52 +/- 3% of the lung area). Atelectasis was not
      correlated with pulmonary vascular resistance or end-systolic
      pressure-volume relationship.The LV contractility and afterload during OLC
      was not significantly different compared with CMV. Compared with baseline,
      the LV end-diastolic volume (66 +/- 4 ml) decreased significantly during
      OLC (56 +/- 5 ml) ventilation and not during CMV (61 +/- 3 ml). Also, CO
      was significantly lower during OLC ventilation (OLC, 4.1 +/- 0.3 l/minute
      versus CMV, 4.9 +/- 0.3 l/minute). CONCLUSION: In this experimental study,
      OLC resulted in significantly improved lung aeration. Despite the use of
      elevated airway pressures, no evidence was found for a negative effect of
      OLC on RV afterload or LV afterload, which might be associated with a loss
      of hypoxic pulmonary vasoconstriction due to alveolar recruitment. The
      reductions in the CO and in the mean pulmonary artery pressure were
      consequences of a reduced preload.</description>
    </item> <item>
      <title>Dynamic 3D echocardiography in virtual reality. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13971/</link>
      <pubDate>2005-12-23T00:00:00Z</pubDate>
      <description>BACKGROUND: This pilot study was performed to evaluate whether virtual reality is applicable for three-dimensional echocardiography and if three-dimensional echocardiographic 'holograms' have the potential to become a clinically useful tool. METHODS: Three-dimensional echocardiographic data sets from 2 normal subjects and from 4 patients with a mitral valve pathological condition were included in the study. The three-dimensional data sets were acquired with the Philips Sonos 7500 echo-system and transferred to the BARCO (Barco N.V., Kortrijk, Belgium) I-space. Ten independent observers assessed the 6 three-dimensional data sets with and without mitral valve pathology. After 10 minutes' instruction in the I-Space, all of the observers could use the virtual pointer that is necessary to create cut planes in the hologram. RESULTS: The 10 independent observers correctly assessed the normal and pathological mitral valve in the holograms (analysis time approximately 10 minutes). CONCLUSION: this report shows that dynamic holographic imaging of three-dimensional echocardiographic data is feasible. However, the applicability and use-fullness of this technology in clinical practice is still limited.</description>
    </item> <item>
      <title>The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13630/</link>
      <pubDate>2005-04-01T00:00:00Z</pubDate>
      <description>AIMS: Sirolimus-eluting stents (SES) have recently been shown to reduce restenosis in selected patients. The impact of this new stent on the use of coronary bypass graft (CABG) surgery or percutaneous coronary intervention (PCI) in clinical practice is yet unknown. Therefore, we investigated the impact of SES on the clinical practice of CABG and PCI in a series of unselected consecutive patients. METHODS AND RESULTS: Between April and October 2002, a policy of SES implantation for all procedures has been instituted in our hospital. In total, 798 patients were referred to PCI and 275 to CABG (SES group). A control group was composed of all interventions (806 PCI and 314 CABG) performed during the preceding 6 months (pre-SES). The main outcome was the occurrence of major adverse cardiac events (MACE) at 15 months. In the SES era, a significant shift was noted in the PCI group towards more multi-vessel stenting (28 vs. 24%; P&lt;0.05), more bifurcation stenting (18 vs. 7%; P&lt;0.0001), and the use of more stents (1.9 vs. 1.5; P&lt;0.05). In the PCI elective patients, a shift was noted towards more three-vessel disease (pre-SES: 16% vs. SES: 23%; P=0.02). Furthermore, we observed a shift in the CABG group towards more impaired LV function (pre-SES: 34% vs. SES: 41%; P=0.02) and towards more three-vessel disease (pre-SES: 67% vs. SES: 75%; P=0.03). Overall, the cumulative MACE percentages at 1 year after coronary revascularization (PCI and CABG combined) decreased from 16.8 to 13.8% (P=0.03). The cumulative MACE percentages in the pure SES group and the pre-SES bare metal stent group at 12 months were 15.6 and 19.8%, respectively (P&lt;0.01). CONCLUSION: The introduction of the SES has certainly had an impact on the treatment strategy of coronary artery disease (CAD). Increased use of these stents allows more complex coronary anatomy to be treated by PCI, and results in lower repeat revascularization rates.</description>
    </item> <item>
      <title>The open lung concept: effects on right ventricular afterload after cardiac surgery. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13447/</link>
      <pubDate>2004-09-01T00:00:00Z</pubDate>
      <description>BACKGROUND: The open lung concept (OLC) is a method of ventilation
      intended to maintain end-expiratory lung volume by increased airway
      pressure. Since this could increase right ventricular afterload, we
      studied the effect of this method on right ventricular afterload in
      patients after cardiac surgery. METHODS: We studied 24 stable patients
      after coronary artery surgery and/or valve surgery with cardiopulmonary
      bypass. Patients were randomly assigned to OLC or conventional mechanical
      ventilation (CMV). In the OLC group, recruitment manoeuvres were applied
      until Pa(o(2))/FI(O(2)) was greater than 50 kPa (reflecting an open lung).
      This value was maintained by sufficient positive airway pressure. In the
      CMV group, volume-controlled ventilation was used with a PEEP of 5 cm
      H(2)O. Cardiac index, right ventricular preload, contractility and
      afterload were measured with a pulmonary artery thermodilution catheter
      during the 3-h observation period. Blood gases were monitored
      continuously. RESULTS: To achieve Pa(O(2))/Fl(O(2)) &gt; 50 kPa, 5.3 (3)
      (mean, SD) recruitment attempts were performed with a peak pressure of
      45.5 (2) cm H(2)O. To keep the lung open, PEEP of 17.0 (3) cm H(2)O was
      required. Compared with baseline, pulmonary vascular resistance and right
      ventricular ejection fraction did not change significantly during the
      observation period in either group. CONCLUSION: No evidence was found that
      ventilation according to the OLC affects right ventricular afterload.</description>
    </item> <item>
      <title>Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). (Article)</title>
      <link>http://repub.eur.nl/res/pub/13445/</link>
      <pubDate>2004-07-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Great concern exists about the ability of the anatomic right ventricle to sustain the systemic circulation in patients with transposition of the great arteries who have undergone a Mustard procedure. A prospective study was made to examine long-term survival, clinical outcome, and right ventricular function 25 years after surgery. METHODS: Ninety-one consecutive patients underwent the Mustard procedure between 1973 and 1980. After 14 years and again after 25 years (range 22-29 years), patients were studied with ECG, echocardiography, exercise testing, and Holter monitoring. RESULTS: The cumulative survival and event-free survival were 77% and 36%, respectively, after 25 years. Reoperation was necessary in 46%. No major loss of sinus rhythm was found. While all patients had good right ventricular function 14 years after repair, 61% of patients showed moderate-to-severe dysfunction after 25 years, when studied by echocardiography. Furthermore, the QRS complex widened and exercise capacity decreased. CONCLUSION: The anatomic right ventricle appears to be unable to sustain the systemic circulation at long-term follow-up and the clinical condition of patients late after Mustard repair is declining. We can expect more deaths or need for heart transplantation in the next decade.</description>
    </item> <item>
      <title>Outcome of patients after surgical closure of ventricular septal defect at young age: longitudinal follow-up of 22-34 years. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13419/</link>
      <pubDate>2004-06-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Long-term survival and clinical outcome after surgical closure of a VSD is poorly documented. Such data are important for the future perspectives, medical care, employability, and insurability of these patients. METHODS: 176 consecutive patients underwent surgical closure of an isolated VSD between 1968 and 1980 in our hospital. A systematic follow-up study was performed in 1990 and again in 2001. FINDINGS: Late survival was poorer than in the general population. Pulmonary hypertension and right ventricular hypertrophy were present in the 4 patients who died suddenly, late after operation. During follow-up no new pulmonary hypertension became manifest. Re-operations were necessary in 6%. Some patients (4%) developed sinus node disease late after repair, requiring pacemaker implantation. At last follow-up (91 survivors) 92% of the patients were in NYHA class I. Pulmonary hypertension was found in 4%, and aorta insufficiency in 16%. Patients experienced difficulties when applying for insurance. CONCLUSION: Among patients with surgically repaired VSDs, late results were good, although some late sudden deaths occurred in the patients with pulmonary hypertension. Furthermore, some patients developed sinus node disease late after repair, requiring pacemaker implantation. Employability is good, but pregnancy and insurance matters need further attention.</description>
    </item> <item>
      <title>Comparison of outcomes after aortic valve replacement with a mechanical valve or a bioprosthesis using microsimulation (Article)</title>
      <link>http://repub.eur.nl/res/pub/8309/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Mechanical valves and bioprostheses are widely used for aortic
      valve replacement. Though previous randomised studies indicate that there
      is no important difference in outcome after implantation with either type
      of valve, knowledge of outcomes after aortic valve replacement is
      incomplete. OBJECTIVE: To predict age and sex specific outcomes of
      patients after aortic valve replacement with bileaflet mechanical valves
      and stented porcine bioprostheses, and to provide evidence based support
      for the choice of prosthesis. METHODS: Meta-analysis of published results
      of primary aortic valve replacement with bileaflet mechanical prostheses
      (nine reports, 4274 patients, and 25,726 patient-years) and stented
      porcine bioprostheses (13 reports, 9007 patients, and 54,151
      patient-years) was used to estimate the annual risks of postoperative
      valve related events and their outcomes. These estimates were entered into
      a microsimulation model, which was employed to calculate age and sex
      specific outcomes after aortic valve replacement. RESULTS: Life expectancy
      (LE) and event-free life expectancy (EFLE) for a 65 year old man after
      implantation with a mechanical valve or a bioprosthesis were 10.4 and 10.7
      years and 7.7 and 8.4 years, respectively. The lifetime risk of at least
      one valve related event for a mechanical valve was 48%, and for a
      bioprosthesis, 44%. For LE and EFLE, the age crossover point between the
      two valve types was 59 and 60 years, respectively. CONCLUSIONS:
      Meta-analysis based microsimulation provides insight into the long term
      outcome after aortic valve replacement and suggests that the currently
      recommended age threshold for implanting a bioprosthesis could be lowered
      further.</description>
    </item> <item>
      <title>Psychosocial functioning of the adult with congenital heart disease: a 20-33 years follow-up (Article)</title>
      <link>http://repub.eur.nl/res/pub/10117/</link>
      <pubDate>2003-04-01T00:00:00Z</pubDate>
      <description>AIMS: Since knowledge about the psychosocial function of adult patients
      with congenital heart disease is limited, we compared biographical
      characteristics, and emotional and social functioning of these patients
      with that of the reference groups. METHODS AND RESULTS: Patients with
      congenital heart disease (N=362, aged 20-46 years), belonging to five
      diagnostic groups, were subjected to extensive medical and psychological
      examination, 20-33 years after their first open heart surgery. All the
      patients were seen by the same psychologist, who examined their
      psychosocial functioning using a structured interview and questionnaires.
      The majority (78%)was living independently and showed favourable outcome
      regarding the marital status. Among married/cohabitant patients,
      25-39-year-olds showed normal offspring rates. None of the 20-24-year-old
      patients had any children. The offspring rate dropped after the age of 40.
      The proportion of adult patients with a history of special education was
      high (27%). Accordingly, patients showed lower educational and
      occupational levels compared to reference groups. As regard to the
      emotional and social functioning (leisure-time activities), the sample
      showed favourable results. CONCLUSIONS: Overall, this sample of patients
      with congenital heart disease seemed capable of leading normal lives and
      seemed motivated to make good use of their abilities.</description>
    </item> <item>
      <title>Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years (Article)</title>
      <link>http://repub.eur.nl/res/pub/10094/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>AIMS: Although studies have suggested good long-term results, arrhythmias, pulmonary hypertension and left ventricular dysfunction are mentioned as sequelae long-term after surgical atrial septal defect closure at young age. Most studies were performed only by questionnaire and in a retrospective manner. The long-term outcome is very important with regard to future employment and acceptance on insurance schemes. METHODS AND
RESULTS: One hundred and thirty-five consecutive ASD-patients, operated on in childhood, were studied longitudinally with ECG, echocardiography, exercise testing and Holter-recording 15 (10-22) and 26 (21-33) years after surgery. During follow-up no cardiovascular mortality, stroke, heart failure and no pulmonary hypertension occurred. Symptomatic supraventricular tachyarrhythmias were present in 6% after 15 years, and an additional 2% occurred in the last decade; 5% needed pacemaker implantation. No relation was found between arrhythmias and type of ASD, baseline data, right ventricular dimensions, or age at operation. Left and right ventricular function and dimension remained unchanged. Slightly more patients had right atrial dilatation at last follow-up. Exercise capacity was comparable with the normal Dutch population. CONCLUSIONS: The long-term outcome after ASD closure at young age shows excellent survival and low morbidity. The incidence of supraventricular arrhythmias is lower than in natural history studies of ASD patients and also lower than after surgical correction at adult age.</description>
    </item> <item>
      <title>Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age (Article)</title>
      <link>http://repub.eur.nl/res/pub/5700/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>Aims Although studies have suggested good long-term results, arrhythmias, pulmonary hypertension and left ventricular dysfunction are mentioned as sequelae long-term after surgical atrial septal defect closure at young age. Most studies were performed only by questionnaire and in a retrospective manner. The long-term outcome is very important with regard to future employment and acceptance on insurance schemes.

Methods and Results One hundred and thirty-five consecutive ASD-patients, operated on in childhood, were studied longitudinally with ECG, echocardiography, exercise testing and Holter-recording 15 (10–22) and 26 (21–33) years after surgery. During follow-up no cardiovascular mortality, stroke, heart failure and no pulmonary hypertension occurred. Symptomatic supraventricular tachyarrhythmias were present in 6% after 15 years, and an additional 2% occurred in the last decade; 5% needed pacemaker implantation. No relation was found between arrhythmias and type of ASD, baseline data, right ventricular dimensions, or age at operation. Left and right ventricular function and dimension remained unchanged. Slightly more patients had right atrial dilatation at last follow-up. Exercise capacity was comparable with the normal Dutch population.

Conclusions The long-term outcome after ASD closure at young age shows excellent survival and low morbidity. The incidence of supraventricular arrhythmias is lower than in natural history studies of ASD patients and also lower than after surgical correction at adult age.</description>
    </item> <item>
      <title>Aortic valve and aortic arch pathology after coarctation repair (Article)</title>
      <link>http://repub.eur.nl/res/pub/8335/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To investigate the incidence of clinical problems related to a bicuspid valve (aortic stenosis and regurgitation) and the incidence of ascending aorta and aortic arch pathology in combination with coarctation repair. PATIENTS: 124 adult patients after surgical correction of aortic coarctation were studied. The incidence of aortic valve, ascending aorta, and aortic arch pathology was determined using echocardiography and magnetic resonance imaging. The median age at coarctation repair was 9 years and at last follow up 28 years. RESULTS: Three patients died from aorta pathology. Aortic valve disease was found in 63% of the patients, requiring an intervention in 22%, at a median of 13 years after coarctation repair. Ascending aorta dilatation was observed in 28% and aortic arch abnormalities in 23%, among whom kinking of the aortic arch was found in 12%. Antihypertensive medication was used in 24%. In the patients with hypertension the age at operation and age at follow up were significantly higher (p = 0.0001 and p &lt; 0.0001, respectively). CONCLUSION: In addition to the well known problems of hypertension and recoarctation, aortic valve and aortic arch pathology are commonly encountered in patients with previous coarctation repair. Aortic abnormalities may predispose to dilatation and dissection, thus necessitating careful lifelong attention in all patients with coarctation.</description>
    </item> <item>
      <title>Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation (Article)</title>
      <link>http://repub.eur.nl/res/pub/9617/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Bioprostheses are widely used as an aortic valve substitute,
          but knowledge about prognosis is still incomplete. The purpose of this
          study was to provide insight into the age-related life expectancy and
          actual risks of reoperation and valve-related events of patients after
          aortic valve replacement with a porcine bioprosthesis. METHODS AND
          RESULTS: We conducted a meta-analysis of 9 selected reports on stented
          porcine bioprostheses, including 5837 patients with a total follow-up of
          31 874 patient-years. The annual rates of valve thrombosis,
          thromboembolism, hemorrhage, and nonstructural dysfunction were 0.03%,
          0.87%, 0.38%, and 0.38%, respectively. The annual rate of endocarditis was
          estimated at 0.68% for &gt;6 months of implantation and was 5 times as high
          during the first 6 months. Structural valve deterioration was described
          with a Weibull model that incorporated lower risks for older patients.
          These estimates were used to parameterize, calibrate, and validate a
          mathematical microsimulation model. The model was used to predict life
          expectancy and actual risks of reoperation and valve-related events after
          implantation for patients of different ages. For a 65-year-old male, these
          figures were 11.3 years, 28%, and 47%, respectively. CONCLUSIONS: The
          combination of meta-analysis with microsimulation enabled a detailed
          insight into the prognosis after aortic valve replacement with a
          bioprosthesis for patients of different ages. This information will be
          useful for patient counseling and clinical decision making. It also could
          serve as a baseline for the evaluation of newer valve types.</description>
    </item> <item>
      <title>Altered arterial expression patterns of inducible and endothelial nitric oxide synthase in pulmonary plexogenic arteriopathy caused by congenital heart disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/9641/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>Flow-associated pulmonary hypertension leads to pulmonary plexogenic
      arteriopathy (PPA), a specific pulmonary vascular disease that includes
      vascular lesions characterized by abnormal vasodilatation and endothelial
      cell proliferation. Increased local production of NO has been suggested in
      this condition. Because reported data on the expression of endothelial
      NO-synthase (ecNOS) have been contradictory, we speculated that the
      expression of the inducible isoform of NOS (iNOS) is enhanced in this form
      of pulmonary hypertension. We investigated immunohistochemically the
      expression of ecNOS and iNOS in lung tissue of patients with
      flow-associated pulmonary hypertension (n = 18) and compared the findings
      with those in patients with increased pulmonary blood flow but normal
      pulmonary artery pressure (n = 10), with congestive vasculopathy (n = 6)
      and control subjects (n = 4). Immunoreactivity for ecNOS and iNOS was
      present both in normal and diseased pulmonary arteries. Marked
      immunoreactivity to both isoforms was present within the advanced lesions
      of PPA, including plexiform lesions. Semiquantitative analysis of
      immunoreactivity, both for ecNOS and iNOS, showed no correlation with the
      severity of morphologic vascular lesions (p = 0.29 and p = 0.23,
      respectively). In contrast to ecNOS, immunoreactivity for iNOS was
      increased in patients with flow-associated pulmonary hypertension compared
      with other patients (p = 0.02). The present study has demonstrated
      enhanced expression of iNOS in patients at risk for advanced PPA, but not
      in patients with other forms of pulmonary arteriopathy. Moreover, high
      expression of both ecNOS and iNOS were present in advanced lesions of PPA.
      These data suggest differentiated roles for different isoforms of NOS in
      the pathogenesis of this specific pulmonary arteriopathy.</description>
    </item> <item>
      <title>Age-related decrease of somatostatin receptor number in the normal human thymus (Article)</title>
      <link>http://repub.eur.nl/res/pub/9466/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>The thymus exhibits a pattern of aging oriented toward a physiological
          involution. The structural changes start with a steady decrease of
          thymocytes, whereas no major variations occur in the number of thymic
          epithelial cells (TEC). The data concerning the role of hormones and
          neuropeptides in thymic involution are equivocal. We recently demonstrated
          the presence of somatostatin (SS) and three different SS receptor (SSR)
          subtypes in the human thymus. TEC selectively expressed SSR subtype 1
          (sst(1)) and sst(2A). In the present study we investigated whether SSR
          number is age related in the thymus. Binding of the sst(2)-preferring
          ligand (125)I-Tyr(3)-octreotide was evaluated in a large series of normal
          human thymuses of different age by SSR autoradiography and ligand binding
          on tissue homogenates. The score at autoradiography and the number of SSR
          at membrane homogenate binding (B(max)) were inversely correlated with the
          thymus age (r = -0.84, P &lt; 0.001; r = -0.82, P &lt; 0.001, respectively). The
          autoradiographic score was positively correlated with the B(max) values (r
          = 0.74, P &lt; 0.001). Because the TEC number in the age range considered
          remains unchanged, the decrease of octreotide binding sites might be due
          to a reduction of sst(2A) receptor number on TEC. The age-related
          expression of a receptor involved mainly in controlling secretive
          processes is in line with the evidence that the major changes occurring in
          TEC with aging are related to their capabilities in producing thymic
          hormones. In conclusion, SS and SSR might play a role in the involution of
          the human thymus. These findings underline the links between the
          neuroendocrine and immune systems and support the concept that
          neuropeptides participate in development of cellular immunity in humans.</description>
    </item> <item>
      <title>In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/8996/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Somatostatin (SS) and its analogs exert inhibitory effects on secretive
          and proliferative processes of various cells via high affinity SS
          receptors (SS-R). SS analogs bind with different affinity to the five
          cloned SS-R subtypes. Octreotide, an octapeptide SS analog, binds with
          high affinity to the SS-R subtype 2 (sst2). SS-R have been demonstrated in
          vivo and in vitro on cells from endocrine and immune systems. Among the
          lymphatic tissues, the thymus has been shown to contain the highest amount
          of SS, suggesting a local functional role of the peptide. We investigated
          the SS distribution and SS-R expression pattern in the normal human thymus
          using autoradiography, membrane homogenate binding studies, and RT-PCR. In
          addition, the effect of SS and octreotide on growth of cultured thymic
          epithelial cells (TEC) was studied. By autoradiography, binding of
          [125I-Tyr0]-SS-28 and [125I-Tyr3]-octreotide was detected in all seven
          thymuses studied. Specific [125I-Tyr3]-octreotide binding was shown on
          membrane preparations from thymuses, while not from cultured thymocytes.
          RT-PCR showed the expression of sst1, sst2A and sst3 messenger RNA (mRNA)
          in the thymic tissue, whereas sst1 and sst2A mRNAs were found in isolated
          TEC. SS mRNA was present in thymic tissue and in isolated TEC. SS and
          octreotide significantly inhibited 3H-thymidine incorporation in 3 of 3
          and 6 of 6 TEC cultures, respectively. The percent inhibition ranged from
          38.8 to 66.8% for SS and from 19.1 to 59.5% for octreotide. In conclusion,
          SS mRNA and sst1, sst2A, and sst3 mRNAs are expressed in the normal human
          thymus. Cultured TEC selectively express sst1 and sst2A mRNA and respond
          in vitro to SS and octreotide administration with an inhibition of cell
          proliferation. These data suggest a paracrine/autocrine role of SS and its
          receptors in the regulation of cell growth in thymic microenvironment.</description>
    </item> <item>
      <title>PJA-BP expression and TCR delta deletion during human T cell differentiation (Article)</title>
      <link>http://repub.eur.nl/res/pub/8990/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>Recombination of deltaRec to psiJalpha will delete the TCR delta gene,
          which is thought to play an important role in the bifurcation of the TCR
          alphabeta versus TCR gammadelta differentiation lineages. We recently
          detected a DNA-binding protein in human thymocytes, the so-called PJA-BP,
          which recognizes the psiJalpha gene segment and might be one of the
          factors involved in the regulation of preferential deltaRec-psiJalpha
          rearrangements. We now investigate PJA-BP expression and its correlation
          with TCR delta gene deletion in thymocytes. Our electrophoretic mobility
          shift assay experiments showed that the PJA-BP is evolutionary conserved
          in human, murine and simian thymocytes. Using a large series of human
          hematopoietic malignancies (n = 30), we conclude that PJA-BP expression is
          thymocyte specific and seems to be restricted to thymocytes committed to
          the TCR alphabeta lineage. Analysis of seven well-defined human thymocyte
          subpopulations showed that preferential deltaRec-psiJalpha rearrangements
          as well as PJA-BP expression can be detected from the immature
          CD34-/CD1+/CD3-/CD4+/CD8alpha+beta- thymocyte differentiation stage
          onwards. These experiments indicate that expression of PJA-BP in human
          thymocytes starts simultaneously with preferential deltaRec-psiJalpha
          rearrangements, which supports our hypothesis that PJA-BP is one of the
          factors involved in the preferential recombination of deltaRec to
          psiJalpha.</description>
    </item>
  </channel>
</rss>